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ABSTRACT 
 
 
 
PATIENT-ORIENTED EVIDENCE-BASED 
TREATMENT DECISION SUPPORT SYSTEM 
(TREATQUEST®) FOR LUNG CANCER  
 
by Danqing Hu 
 
The University of Wisconsin-Milwaukee, 2013 
Under the Supervision of Professor Hemant Jain. 
 
Involving patients in healthcare decisions makes a significant and 
enduring difference to healthcare outcomes. One challenge for patients is the lack 
of evidence-based information and tools to support their decision making. 
Although patients have access to significant information through internet and 
other sources, it is not personalized for their specific situation. This dissertation 
attempts to help patients acquire evidence-based information relevant to their own 
situation, so they can make a more informed decision in co-operation with their 
physicians. Lung cancer has been selected as a focus for this study because lung 
cancer presents very complex decision making situation and is the leading cause 
of cancer deaths in both men and woman in every ethnic group worldwide. The 
prototype decision support system for lung cancer is called TreatQuest®. This 
system allows users to create their own profile, access cases similar to their case, 
and learn about treatment options. The evidences for the treatment were extracted 
from public data and knowledge gained from guideline. The effectiveness of 
patient-oriented evidence-based approach was validated by having a group of 
patient use the system. TreatQuest® is one of the first system developed to 
 
ii
 
 
support patient’s treatment decision process, which represent the most recent 
trend in delivery of healthcare services. Results from this study show that such a 
patient-oriented decision support system provides an effective way to help 
patient receive more personalized information and make informed treatments. In 
summary, patient-oriented evidence-based decision support systems such as 
TreatQuest®, can improve the decision quality for patients. Also, such systems 
can improve health care decisions that are made with the active participation of 
fully informed patients. Therefore, patient-oriented evidence-based decision 
support systems can have significant impact on the healthcare industry.  
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Chapter 1 Introduction 
 
 
1. 1 Problem Definition 
Among many difficult decisions that the newly diagnosed cancer patients 
have to make, the toughest and also the most important is which treatment should 
be used. As the initial treatment bears critical consequence for the overall 
treatment outcome, they almost have to make the best decision right away. 
Unfortunately, these patients and their family will quickly realize that they are not 
well prepared to make such a high-stake decision, even with the help from the 
physicians. Most information from various educational materials or the Internet 
tends to be general in nature, thus offers little help for their specific cases. On the 
other hand, doctors usually make treatment decisions based on clinical practice 
guidelines and their personal experience. Research has found a large variation in 
their treatment practice due to the availability of clinical and demographic 
information (Phillips-Wren et al., 2008 [1]) as well as sensitivity to patient 
preference or physician and specialist supply (Starfield et al., 2005[2]; Wennberg 
et al., 2003[3]). 
One way to help new cancer patients is through developing a patient-
oriented treatment decision support system, which has actually become a new 
trend in health care delivery. Different from the passive role many patients used to 
take, patients today are better educated and more actively involved in treatment. 
While a number of clinical decision support systems (CDSS) and clinical 
knowledge management (CKM) systems have been established, their targeted 
users are usually not patients. Instead, their goal is to serve healthcare service 
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providers, such as physicians, hospitals staff, medical researchers, and members 
of large healthcare organizations. What is in great need is a patient-oriented 
support system that uses evidence-based information and industry guidelines to 
help patients to communicate with their physician and to make informed 
treatment decisions. 
1. 2 Gaps in Research 
 
A thorough survey was conducted for lung cancer treatment related 
information on popular health-related websites, including WebMD, PubMed and 
National Cancer Institute (NCI). As expected, these websites offer well-structured 
information on symptoms, types, diagnosis, tests, treatment, and care. However, 
no patient-oriented treatment related decision support function was found. Using 
these websites, patients can further educate themselves on the disease but will not 
be able to get information specific enough to their profile. Nor can they get 
substantive help in selecting an appropriate treatment.   
To investigate how much treatment decision support information is 
available elsewhere, three popular medical support websites were examined. First, 
the WebMD website offers a tool called Cancer Health Risk Check. Its main 
function is to give a risk estimate for people who have not been diagnosed with 
cancer, which clearly does not apply to patients already diagnosed. Second, 
searching for treatment-related information for lung cancer was conducted on the 
PubMed website. Keywords entered included lung cancer treatment, lung cancer 
treatment decision support system, lung cancer treatment knowledge management 
system, lung cancer treatment aid system, and lung cancer therapy. The results 
returned were quite discouraging in that very few articles were found. The third 
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source is the NCI website. This website offers not only general information on 
different types of cancer but also summative information from Physician Data 
Query (PDQ), a comprehensive cancer database. This database contains 
summaries on a wide range of cancer topics, such as a registry of over 8,000 open 
and over 19,000 closed cancer clinical trials from around the world, a directory of 
professionals who provide genetics services, and the NCI dictionary of cancer 
terms and drug dictionary. In addition, PDQ also provides cancer information 
summaries in both patient and health professional versions for all kinds of cancer. 
The patient version is written in less technical language than the health 
professional version. While there is apparently abundant information on the NCI 
website, it gives cancer patients no tool or service to acquire treatment 
suggestions or recommendations based on their individual needs.  
1. 3 Goals and Research Questions 
 
To address the above gaps, this dissertation study builds a patient-oriented, 
evidence-based treatment decision support system to help cancer patients to make 
more informed decisions. This system aims to synthesize high-quality public data 
with specific cases, offer analytical services, and provide patients with 
information on multiple treatment options. The prototype system will focus on 
lung cancer patients but can be easily extended to other types of cancer. This 
system is named TreatQuest® to underscore its primary mission as the quest for 
treatment information. Lung cancer patients are selected as the focus as it is the 
leading cause of cancer deaths in both men and woman as well as in almost every 
ethnic group worldwide.  The American Cancer Society data show that in US 
alone, there were 219,440 new lung cancer cases and 159,390 deaths from lung 
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cancer in 2009 (Jemal et al 2009 [4]). Put into a different perspective, lung cancer 
took 437 lives every day.  
The primary goal of the TreatQuest® system is to integrate the vast 
amount of information on cancer in an effective way so that users can easily 
obtain information relevant to the characteristics of their specific case and to the 
kind of decisions they are going to make. To achieve this, TreatQuest® system 
acquires and process different types and levels of data and information. These 
data include the raw statistical data (e.g. the SEER data), lung cancer treatment 
information from relevant websites (e.g. WebMD). TreatQuest® also incorporate 
the latest guidelines (e.g. the National Comprehensive Cancer Network (NCCN) 
guidelines for lung cancer). Based on these data, functions are built to allow 
patients to conduct queries for retrieving disease information, similar cases, and 
various treatment options.  
In the TreatQuest® system, the SEER data serves as the primary source. 
This data offer a wide spectrum of demographic information from which almost 
any patient will be able to find similar cases at both local and population levels. 
By using data mining techniques, important information can be extracted under 
various quest criteria. The retrieved information of similar cases can then be 
integrated into summarized information at the current level. For example, using 
the TreatQuest® system, a patient can easily look up similar cases. From there, if 
the patient is not certain about the sequence of treatment options, he or she can 
ask for information on the distribution of these similar patients on the sequence of 
treatments, such as the percentage of patients receiving surgery first, receiving 
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radiation therapy first, and receiving combined therapy. Specific information like 
this will guide patients in selecting an appropriate treatment plan.  
The focus of this study is on the development and evaluation of the 
TreatQuest® system from both theoretical and practical perspectives. 
Specifically, the following research questions are addressed: 
 
1. How can a patient-oriented decision support system with evidence-
based information and knowledge help patients to make informed 
decisions? 
2. How to develop a patient-oriented decision support system that is 
based on large-scale data and industry guidelines?  
3. How to evaluate the effectiveness of a patient-oriented decision 
support system? 
1. 4 Significance of the Study 
 
Newly diagnosed cancer patients need both standardized and 
customized information to make informed treatment decisions. While the 
standardized information can be obtained from various guidelines, online 
resources, and educational materials with considerable ease, the much-needed 
customized information is hard to come by. The real power of the 
TreatQuest® system lies in the high-quality customized information that it is 
able to generate. Such a system will help to alleviate the stress and anxiety that 
many patients experienced accumulate in searching for the optimal treatment 
option. More importantly, it will present reliable unbiased medical information 
in a language that patients can understand and use.  
TreatQuest® can also complement the guidance and services that 
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healthcare providers currently offer. This system will greatly improve 
patients’ engagement and involvement, which has been shown to be 
indispensable in cancer treatment. Utilizing a semi-structured decision support 
system and the latest standards in evidence-based medicine, patients and 
caregivers are in a good position to share the current and case-specific 
information with the physicians, who in turn, will have better chance to 
deliver the most appropriate treatment. 
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Chapter 2 Literature Review 
 
2.1 Patient Involvement as a Global Trend 
 
The rapid advances of information technology along with the dramatic 
social and legal changes in the healthcare industry have promoted a higher degree 
of involvement of patients in the medical decision making process. As a result, 
more and more research has been devoted to the question on how to increase 
patient participation. According to a recent review published in the journal 
Cochrane Database of Systematic Reviews, conducted in the United 
States(Kinnersley et al., 2011[5]), patients who participated in informed decision-
making were 20 percent less likely to choose costly surgery over medication than 
other patients. In Belgium, an investigation of 128 advanced cancer patients in 13 
hospitals (Pardon et al., 2009 [6]) revealed that almost all patients were interested 
in obtaining more information on diagnosis, treatment, cure rate, and life 
expectancy. Some patients also wanted information on palliative care (63.5%) and 
end-of-life decisions (56.8%). This study clearly indicates that while the need of 
patients may vary, they all want to be better informed. In Japan, a study 
conducted by Watanabe and Takahashi (Watanabe et al., 2008 [7]), investigated 
the actual preference of Japanese people on the involvement in treatment decision 
making. Cancer patients recruited from a cancer self-help group in Tokyo were 
interviewed on how they made decisions on cancer treatment. This study finds 
that patients’ views on their preferred role in the decision making process can 
vary substantially from complete physician control to complete patient control. 
Overall, the patients with more control over their decision are more satisfied. One 
key factor that affects the satisfaction level is how well the preferred involvement 
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has been met by the actual involvement. This study suggests that to increase 
patient satisfaction, healthcare professionals should assess individual patient 
preferences first and provide healthcare services accordingly. Moreover, an 
environment should be created to facilitate patients in expressing their 
preferences.  
 A joint effort by researchers from Australia and the United Kingdom 
(Gaston and Mitchell 2005[8]) systematically reviewed what information was 
given to and what decisions were made by patients with advanced cancers. The 
results show that almost all patients express the desire to be given all the 
information. Meanwhile, about two-thirds expressed the interest in actively 
participating in decision-making. Higher educational level, younger age and 
female gender were indicative of stronger desire to participate. Active decision 
making was also found to be more common in the patients with certain cancers 
(e.g. breast) than others (e.g. prostate). This study concludes that the past 40 years 
has witnessed a shift from treating patients as passive recipients to active 
consumers who demand a higher level of autonomy. This study uncovers many 
benefits of involving patients in health-care decisions, such as better compliance 
with treatment and increased satisfaction of both patients and healthcare 
providers. Possible disadvantages are the extra time and therefore higher cost, 
inflated patient anxiety and regret in cases that an adverse outcome ensues as a 
result of a patient-driven decision. 
 Researchers from the United Kingdom (Elwyn et al., 2000[9]) interviewed 
experienced general practitioners on their attitude towards patient involvement in 
decision making and on the necessary contextual factors, competencies, and 
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stages to achieve satisfactory shared decisions. These clinicians listed 
interpersonal skills and information requirements as major obstacles to shared 
decision making. In addition, they viewed involvement as an implicit ethos that 
should permeate medical practice. Their study result indicated that experienced 
general practitioners with educational roles have positive attitudes to the 
involvement of patients in decisions, provided the process matches the role 
individuals wish to play.  Besides that, Bekker (Bekker, 2010 [10]) studied how 
the use of International Patient Decision Aids Standard (IPDAS) collaboration 
checklist affected patients in making treatment choices. These authors show that 
IPDAS has been promoted as an aid to help professionals engage in shared and/or 
patient-centered care and its domain has been established mainly by experts’ 
opinions of best practice.  
 In summary, cancer patients have been shown to have a higher level of 
desire and perceived participation in medical decision making than other patients 
(Ernst et al., 2010 [11]). It is increasingly common for them to take a more active 
role in the decision making process.  
2.2 Shared Decision Making 
 
The most commonly cited and generally accepted conceptualization of 
shared decision making was defined by Charles (Charles et al., 1997[12]). These 
authors define the key features of shared decision-making as ‘involvement of both 
the patient and the doctor, a sharing of information by both parties, both parties 
taking steps to build a consensus about the preferred treatment, and reaching an 
agreement about which treatment to implement’. Over the past few decades, the 
paternalistic health care style has gradually fallen out of favor. Instead, the 
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patient-centered model has become a new norm (Stewart and Brown, 2001[13]). 
The patient-centered model emphasizes patient autonomy, informed consent, and 
empowerment. 
The shared decision making (SDM) work is also part of the evidence-
based medicine movement starting from the 1980s. This movement focuses on 
providing evidence about medical alternatives to healthcare providers and patients 
in order to improve their decision-making. This movement has received high level 
of policy support in many countries (Coulter, 2001[14]; Coulter and Ellins, 2006 
[15]). On the other hand, doubts have also been cast on whether the shared 
decision-making can be applied to all patients (Brundage et al., 2005 [16]; Deber 
et al., 2007 [17]; Edwards et al., 2005[18]). Other researchers have also 
questioned its practicality in some situations (Berry, 2007[19]; Towle et al., 
2006[20]). 
 Shared decision-making has led to the birth of new organizations, 
conferences, projects, and standards.  For example, the primary mission of the 
International Shared Decision Making (ISDM) Conference is to create ethical 
standards for informed consent and to provide technology assessment for shared 
decision making and patient-centered care (Margaret, 2008 [21]). The meetings of 
the Society for Medical Decision Making and the International Society for 
Technology Assessment in Health Care (ISTAHC) are extra venues for 
researchers to share idea on SDM. Organizations such as the Institute for Health 
Sciences (IHS) and European Association for Communication in Health Care 
(EACH) have interests in shared decision making as well. As a collaborative 
enterprise, the International Patient Decision Aid Standards (IPDAS) aims to 
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identify research gaps, perform basic research in decision science and cognition, 
support a set of criteria to be applied to patient decision tools, and stimulate 
development of the field. 
 While increased patient involvement and shared decision-making have 
been shown to be beneficial in many ways, such as better quality of care, higher 
satisfaction for both patients and healthcare providers, and improved self-esteem 
for patients (Crawford et al.,2002 [22]), in practice, they are not widely adopted 
(Carlsen and Aakvik, 2006 [23]). Major barriers to their implementation include 
attitudes, skills, and time availability for the providers (Gravel et al., 2006 [24]). 
As always, decision-making process for health professionals is highly influenced 
by personal preferences, experiences, relationships, and structural constraints 
arising from class, education, ethnicity, and culture (Longo et al., 2006 [25]). On 
the patients’ end, their experience may also vary by situation. Consequently, some 
of them may take contradictory or ambivalent stands on assuming responsibility 
for their health and health care at different times and/or different situations. 
2.2.1 Physician’s Perspectives 
 
Previous studies have found significant variability in how physicians view 
the involvement of patients in medical decision making. First of all, not all 
physicians favor patient involvement (Bruera et al., 2001 [26]). What is suggested 
is that rather than forcing a uniform approach on all patients, physicians should 
directly ask patients about their preferred level of involvement. Second, external 
factors such as gender, geographical region, culture, and family background can 
all exert influence on patient decision making (Baile et al., 2002[27]). For 
example, women have been shown to be easier to discuss about hospice referral 
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than men. They are less likely to withhold prognosis from the family. Lastly, 
experienced general physicians with educational roles have more positive 
attitudes towards the involvement of patients in decision making (Elwyn et al., 
2000 [28]) than those not engaged in education. These physicians are more ready 
to take a cooperative approach in solving clinical problems.  
 In general, one consensus is to let patients decide how much information 
should be shared and how much family involvement is appropriate. In practice, 
providers should ask directly and early how the patient would like information to 
be shared. This patient-focused approach not only empowers patients but also 
relieves physicians from taking all the responsibility for the treatment outcome. 
2.2.2 Patient’s Perspectives  
 
Evidences suggest that patient’s preferences for receiving information on 
treatments and for taking responsibility for treatment decisions vary as well.  
Preference for a more active role is associated with increased level of education, 
younger age, and female gender (Gaston and Mitchell, 2005[8]). Active decision-
making was more common in patients with certain cancers (e.g. breast) than 
others (e.g. prostate). Degner (Degner et al., 1997 [29]) has found that 22% of 
women with breast cancer wanted to select their own treatment, 44% wanted to 
select their treatment in collaboration with their physician, and 34% wanted to 
delegate this responsibility totally to their physician. A post-treatment survey 
found only 42% believed they had achieved their preferred level of control in 
decision making and approximately 15% believed they had been pushed to 
assume a more decisional role than they wanted.  
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 Researchers in Canada has also investigated the response of lung cancer 
patients about their desired and actual levels of involvement in treatment decision 
and about information needed for treatment decision-making (Davidson et al., 
1999 [30]). They found 43% of patients desired a collaborative role in their real 
treatment decision at the beginning of treatment. After the treatment, 57% of 
patients desired an active or collaborative role. Generally, patients wanted a wide 
variety of information on treatment options. Types of information rated as 
‘essential’ to treatment decisions were details of the treatment regimen, early and 
late side-effects, survival, and effects of treatment on disease symptoms. These 
findings are in sharp contrast with results from a study in Germany, where 60.2% 
of patient actually desired a more passive role with hematological disease (Ernst 
et al., 2010 [11]). In other words, the majority of the patients would rather leave 
their medical decisions to physicians.  
 In conclusion, many cancer patients prefer an active role in their 
treatment. The desire of involvement is affected by factors like disease type, 
disease stage, age, gender, education level, as well as family involvement. 
2.2.3 Evaluating Shared Decision Making 
 
While SDM is viewed by many as the gold standard for medical care 
(Charles et al., 1999 [31]) and there is evidence that SDM does lead to positive 
patient outcomes (Gattellari et al., 2001 [32]; Fallowfield et al., 1990 [33]; Street 
and Voigt, 1997[34]), others have argued that SDM is not always realistic or 
preferred by patients (Butow et al., 2006 [35], Lam et al., 2003 [36]). As the 
concept of SDM is relatively new, not many instruments have been published to 
evaluate its effectiveness. 
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SDM should be viewed as a flexible approach for patient participation 
with different levels of applicability, contingent upon settings, time, and patient 
preference (Mazur and Hickman, 1997[37]). With regard to measurement issues, 
both generic and disease-specific instruments should be used to capture the results 
from different angles(Miller, 1995 [38]). Generic instruments can be applied to 
many types of diseases and may also be less costly (Deber, 1996 [39]). However, 
changes in generic measures can be hard to interpret and they may not be 
sensitive enough to detect small changes in specific populations or diseases 
(Miller, 1995 [38]), which can be picked up by more specific instruments (Katon, 
1981 [40]).  
In recent years, a number of SDM coding systems and measures have been 
published, such as the Decision Support Analysis Tool (DSAT) (Guimond, 
2003[41]), the Observing Patient Involvement (OPTION) scale (Elwyn, 2003 
[42]), the Decision Analysis System for Oncology (DAS-O) scale (Brown et al., 
2003 [43],  the Shared Decision-Making Questionnaire (SDM-Q) (Simon et al., 
2006[44]),  the Autonomy Preference index (API) (Ende et al., 1989 [45]), the 
Control Preference Scale (CPS) (Degner and Sloan,1992 [46]), the Patients’ 
Perceived Involvement in Care Scale (PICS) (Lerman et al., 1990 [47]) and the 
Combined Outcome Measure for Risk Communication and Treatment Decision 
Making (COMRADE) (Edwards et al., 2003[48]). These coding systems share 
common characteristics but each also has its own uniqueness.  
Many behaviors were similarly coded in the OPTION, DAS-O and DSAT 
systems. The DAS-O and OPTION coding systems explained a significant 
moderate proportion of the variance in satisfaction with the doctors’ SDM 
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skills(Butow et al., 2009[49]).The DSAT has been developed primarily to code 
decision support provided outside the medical consultation, but many aspects of 
this coding system relate to issues regarded as important in SDM within the 
consultation, including presenting options, discussing the pros and cons of these 
options, and eliciting patient preferences and values. According to Weiss et al 
(Weiss and Peters, 2008[50]), DAS-O was strongly correlated with OPTION. 
DSAT was moderately correlated with DAS-O and OPTION. Decisional 
satisfaction and satisfaction with doctor SDM skills were significantly correlated 
with OPTION and with DAS-O. 
In general, these systems have not been able to deliver satisfactory results. 
One possible reason is the variability in patient preferences for shared decision 
making is confounded with whether or not they are satisfied with consultation 
altogether. One exception is the satisfaction measures used in the oncology 
setting, where highly skewed distributions have been observed with most patients 
expressing extremely high satisfaction scores (Brown et al., 2008 [51]). 
Since not all coding systems are equally valid, it is important to ensure 
that optimal systems are used in analyzing doctor and patient behaviors. 
Meanwhile, while shared decision making by nature involves both clinicians and 
patients, coding systems designed for health practitioners should not be used for 
patients. At present, not many instruments focus on both parties (Braddock et al., 
1999 [52]). To obtain a comprehensive evaluation of SDM, instruments and 
coding systems that analyze both doctor and patient behaviors need to be 
combined.  
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2.3 Current Status of SDM 
 
2.3.1 Models of Decision Making in Medical Care Context 
 
In studying the patient’s role in medical decision making, especially in 
handling the conflict between autonomy and health, between the values of the 
patient and the values of the physician, different models of making healthcare 
decisions have been proposed.  Elwyn et al (Elwyn et al., 1999 [53]) has modeled 
the clinical decision-making as a spectrum from a paternalistic model at one end 
to the informed choice model at the other end (Charles et al., 1997[54]). In the 
middle of this spectrum lies the model of shared decision-making (Figure 2-1). 
Paternalistic            Shared Decision-Making         Informed Choice 
Figure 2-1:  Spectrum of Patient Clinician Interaction 
The paternalistic model is also known as the parental or priestly model. 
This model obliges patients to seek ‘expert’ help and to comply with the medical 
regimen. It is a model where physicians do what is thought best for patients 
without necessarily eliciting the latter’s input. The ‘informed choice’ decision-
making model stands on the opposite end of the spectrum. This model, also 
known as the ‘consumer model’, describes a process whereby patients receive 
information from their physicians about treatment choices but they will make the 
final decisions on the treatment. Under this model, a patient’s values will be well 
defined and appreciated. It is the physician’s obligation to provide the patient with 
all medical information relevant to the disease and available interventions. The 
patient then has both the information required and the personal preferences 
necessary for decision-making.  One concern about the ‘informed choice’ model 
is the possible high anxiety level the patient may feel due to the sole responsibility 
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in decision making (Quill and Brody, 1996 [55]). In the extreme case, they may 
feel being abandoned by the doctor. While vastly different, neither the 
paternalistic model nor the informed choice model involves both physician and 
patient simultaneously in the clinical decision making process, giving room to a 
more compromised model.  
 The shared decision making model, by definition, represents a process in 
which physicians and patients share decision making. This model has attracted 
more and more attention and been advocated as the ideal model for physician-
patient interaction. In addition to ethical reasons that have prompted the use of 
SDM, there is also growing evidence that this is the approach most patients desire 
for. 
Research has shown that when patients take a more active part in making 
decisions about their care, treatment outcomes turn out to be better. One example 
is the achievement of improved diabetic control in studies by Greenfield, Kaplan 
and Brody (Greenfield et al., 1988[56]; Kaplan et al., 1989[57], Brody et al., 
1984[58]).  Recent work also reveals the complexity that underlies the apparent 
relationship between patient involvement and improved health outcomes. Street 
and Voigt (Street and Voigt, 1997[59]) demonstrates that the patient’s perception 
of decision control is a key issue with both stable and dynamic characteristics, 
depending on the patient’s personality, their involvement within the consultation, 
and the eventual health outcome. Huygen et al (Huygen et al., 1992[60]) shows 
that certain types of consulting styles could improve the health of patients across a 
practice list. There will also be times when patient preferences will be in direct 
conflict with clinical guidelines. One classical example is the wish to receive 
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antibiotics for viral illnesses. These conflicts may threaten doctor–patient 
relationship (Bradley, 1992 [61]) and health outcomes (Little et al., 1997 [62]). 
Shared decision-making will need to accommodate such contradictory beliefs. 
Stewart (Stewart et al., 1997[63]) reported that where patients ‘perceived’ that 
they had achieved ‘common grounds’ with physicians, there were fewer demands 
on laboratory and referral services.  To sum up, potential positive outcomes from 
the shared decision model are the provision of clear information, input from 
patients, shared information and shared decisions, agreement between the patient 
and the doctor on problems and the treatment plan, and finally, a positive and 
reliable relationship between the patient and physician. 
2.3.2 Characteristics of Shared Decision Making (SDM) 
 
The essence of a shared decision making includes two broadly defined 
aspects: sharing information and sharing decision. Sharing information and 
sharing decisions are not synonymous (Ong et al., 1995 [64]).They have separate 
goals and require different skills. Shared decision-making will not happen unless 
preceded by the sharing of information. Charles et al (Charles et al., 1997[12]) 
summarized the four characteristics of shared decision making process as follows. 
First, shared decision-making involves at least two participants — the doctor and 
the patient — and often many more, such as patient family or professional 
colleagues. Second, both parties take steps to participate in the process of 
treatment decision-making. Third, information sharing is a prerequisite to shared 
decision making. Fourth, a treatment decision is made and both parties agree to 
the decision. 
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In the shared decision making model, information sharing is of utmost 
importance. It requires an open two-way exchange of information and opinions 
about probabilistic data so that medical decisions will be made based on a better 
understanding of options and outcomes. This process cannot occur within a 
doctor-centered consultation. Instead, consultation has to be patient-centered 
(Stewart et al., 1995 [63]). Such a consultation is also known as ‘risk 
communication’ for the fact that the patient is given information with unknown 
impact. The information can affect the patient’s decision either positively or 
negatively. In that sense, while doctors are increasingly aware of the need to 
inform patients about treatment options and encourage patients to be more 
involved, they should also disclose the benefits and risks associated with each 
treatment. At the same time, individual choice can be sensitive and involve value 
judgments. Same treatment effect may be interpreted as trivial by some patients 
but as significant by others. 
Sharing information based on patients’ needs can reduce the risk or 
negative impact and maximize the benefits of patient-centered medical care. For 
example, as mentioned above, a sizeable minority of cancer patients prefer to 
relinquish decisional control, particularly if faced with a dire prognosis. 
Advocating active patient involvement for those patients would endanger, rather 
than engender, patient autonomy. Given the current emphasis on patient 
participation, understanding patient preferences can determine what kind of 
information to share, how much information to share, and to what degree the 
information should be shared.  
2.3.3 Strategies of Shared Decision Making (SDM) 
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As SDM requires a commitment from both patients and physicians, 
strategies for the advancement of SDM have either focused on patients, 
physicians, or both. For patients, the use of patient decision aids (PDAs) is a well-
acknowledged and increasingly popular means to prepare for SDM. For 
physicians, SDM training programs are offered to improve SDM skills. The 
training programs along with PDAs have greatly facilitated SDM in medical 
consultations.  
For physicians, research (Loh et al., 2007 [69]) has found that the SDM 
training is attractive to a broad range of physicians and most physicians displays  
a positive attitude towards it. Most SDM trainings orientate around a set of SDM 
core competencies, defined in the framework for SDM (Brody et al., 1989[66]; 
Street and Viugt, 1997[34]). These competencies exceed the basic communication 
skills in that advanced skills are required for partnership-building, risk 
presentation, discussion of evidence-based information, and explicit dialogue. 
The effectiveness of SDM training was evaluated in Elwyn et al.(Elwyn et 
al., 2004[67]). The clinicians in that study demonstrated greater involvement of 
patients in treatment decision making after participating in skill development 
workshops. It appears that the most effective way to increase clinicians’ abilities 
to involve patients is to familiarize them with detailed information before 
discussing skill development techniques. After the workshop, the clinicians were 
able to integrate the risk communication aids by using the graphical illustrations 
in scheduled review consultations with real patients after the training intervention. 
As part of a national German research consortium called ‘‘Patients as Partners in 
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the Medical Decision Making Process,’’ (Loh et al., 2007[68]), a clinical trial was 
conducted to explore the possibility of implementing SDM training for physicians 
in practice. Results suggest that for the SDM training be attractive to a broad 
range of physicians. Overall, physicians from 13 specialties signed up for the 
training. Higher interest was observed in the more “people-oriented’’ specialties, 
such as family medicine, probably due to the fact that physicians in those fields 
tend to value the physician–patient relationship more than their counterparts in 
more ‘‘technology-oriented’’ specialties. Approximately 94% of the participants 
in that sample showed a positive attitude towards SDM. This result is consistent 
with other studies showing SDM is the most well respected interaction model 
among physicians (Murray et al., 2007 [69]; Charles et al., 2004[70]).   
Although most physicians view SDM favorably, the actual use of SDM 
lags far behind the ideal implementation level. As a result, many patients do not 
feel involved to the desired extent. It seems that though physicians are motivated 
and like the idea of SDM, they are not well prepared to implement it yet. When 
physicians choose to adopt a SDM model, they are faced with the challenge of 
providing patients with information and making shared decisions with them. All 
these require advanced SDM communication skills that may not be present yet. 
This suggests that more efforts should be put into disseminating SDM training 
and new tools should be developed  so that information like risks and benefits can 
be shared more easily.  
As a patient-centered model, shared decision-making has the potential to 
improve patients understanding and satisfaction, patient adherence, and a 
reduction in the use of resources such as laboratory services and referral. 
22 
 
However, with more patient’s involvement comes new responsibilities, such as 
evaluating risks and benefits of each treatment. Patient Decision Aid or PDAs 
have been introduced to help patients analyze such risks and benefits. The interest 
in PDAs has been rising. The next section will be devoted to the review of the 
utility of PDAs in SDM.  
2.4 Decision Aids 
 
2.4.1 Concept of Decision Aids 
 
Decision aids commonly refer to tools that are designed for patients or 
people facing healthcare decisions. They aim to help people deliberate, 
independently or in collaboration with others, about options. This is usually done 
by considering relevant attributes in forecasting short, intermediate, and long-term 
outcomes and consequences. Healthcare providers may also use decision aids as 
adjuncts to prepare patients for decision making. Decision aids usually provide 
descriptive information on the disease or condition, probabilities of outcomes 
tailored to a person’s health risk factors, an explicit clarification of values 
exercise, information on others’ opinions, and guidance in the steps of decision 
making and communicating with others. Decision aids may be administered with 
the use of various media, such as brochures, videotapes, decision boards, 
interactive videodiscs, interactive computer programs, audiotapes, audio-guided 
workbooks, pamphlets, and group presentations. Excluded from the definition of 
decision aids are passive informed consent materials, educational interventions 
that are not geared to a specific decision, and interventions designed to promote 
compliance with a recommended option rather than a choice based on personal 
values. 
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2.4.2 Types of Decision Aids 
 
Although all decision aids provide information on the benefits and risks of 
treatment options, the difference lies in how the information is presented. Some 
are interactive and others are non-interactive. Interactive decision aids use 
interactive multimedia programs such as videodisks, computer programs, and 
personal interviews. Non-interactive decision aids use more traditional media, 
such as decision boards, videos, brochures, posters, pamphlets, written vignettes, 
written materials, and checklists, prompt lists, other consultation session based, 
scripted counseling, and audio-guided workbook.  
2.4.3 Utility of Decision Aids 
 
Decision aids aim to provide accurate, balanced, and tailored information 
to help patients improve their knowledge and skills in shared decision making. 
For example, using the probability of different treatment outcomes computed by a 
decision aid, patients can form a more realistic expectation of treatments (Tversky 
and Kahneman, 1981[71]). They can express their thoughts in the terms familiar 
to physicians (Fischhoff et al., 1980[72]).  With functions which provide by 
decision aid, they will help patients handle the uncertainty in choosing treatment 
options with more confidence (O’Connor, 1995 [73]).  Decision aids offer one of 
the most effective means to ensure that patients are informed about their treatment 
options. These aids can come in the form of a brochure, video, interactive 
website, or a combination, and they provide balanced, evidence-based information 
about medical conditions, the patient’s treatment options and the tradeoffs 
involved in each option. High-quality decision aids can help patients understand 
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their various options and the potential outcomes within the context of their own 
preferences and values.   
2.4.4 Efficacy of Decision Aids 
 
Considerable research has been devoted to studying the efficacy of 
decision aids. Overall, results have been positive. Decision aids have the potential 
to increase the likelihood that choices are based on better knowledge, realistic 
expectations of outcomes, and personal values for cancer patients. Annette et al 
(Annette et al., 1999[74]) reviewed published evidence on the efficacy of decision 
aids on cancer treatment outcomes. They summarized the evaluative studies from 
the annotated bibliography (O’Connor  et al., 1999[75]) by searching databases 
like MEDLINE®, CINAHL®, PsycINFO®, and Current Contents®. They also 
manually searched Medical Decision Making and Health Expectations. Three 
types of studies were included. The first type was before/after studies that 
evaluated decision aids with patients at the point of decision making. The second 
type was randomized trials that evaluated decision aids in comparison to “usual 
care” with patients at the point of decision making. The third type was 
randomized experiments comparing different methods of decision support in 
decision aids either with patients at the point of decision making or with 
volunteers making hypothetical choices. Their research results indicate that 
cancer-related decision aids are acceptable to patients and especially helpful to 
those who are uncertain in making decisions. 
Stacey el al (Stacey et al., 2008[76]) conducted randomized trials of 
cancer patient decision aids. They conclude that patients exposed to decision aids 
are more likely to make higher-quality decisions. Randomized trials of patient 
25 
 
decision aids were also studied in Annette and O’Connor(Annette and O’Connor, 
2007 [77]).Their findings include that decision aids can increase knowledge, 
lower decisional conflict, and encourage more active patient participation in 
decision making. However, decision aids have impact on patient anxiety and 
satisfaction level during the decision making process.  
2.4.5 Implementation of Decision Aids 
 
The implementation of decision aids is based on decision theories from 
economics and cognitive psychology (Stacey et al., 1997[76]; Annette et al., 
2007[77]; Keeney et al., 1976[78]). These theories describe decision making by 
options, outcomes, and probabilities of outcomes so that patients can make value 
judgment on the benefits versus the risks. Many decision making frameworks 
broaden this cognitive perspective by including emotional, social, and 
environmental dimensions (Tversky et al., 1981[79]; Fischhoff et al., [80]; Janis 
et al., 1977[81]; Orem, 1995[82]; Norbeck, 1988[83]). For example, the Ottawa 
Framework (O’Connor  et al., 1998[84]) identifies several determinants of health 
care decisions that may be modifiable by decision aids. The goal is that the 
decisions made are more likely to be: 1) informed (i.e., based on better knowledge 
and realistic expectations), 2) consistent with personal values, and 3) actually 
implemented. In clinical practice, successful implementation of patient decision 
aids requires access to the interventions, practitioners’ awareness and skills in 
using those interventions, and environmental structures that support their use 
(Graham and Logan, 2004 [85]).  
 The Cochrane Inventory of Patient Decision Aids has over 500 decision 
aids. Out of this huge inventory, about 200 are currently available (Stacey et al., 
26 
 
2008 [86]).These aids come from both academic institutions and health 
information organizations. Examples of the cancer-related aids are available from 
the Foundation for Informed Medical Decision Making (www.fimdm.org), 
Healthwise (www.healthwise.org), the Mayo Clinic(www.mayoclinic.org), and 
the Ottawa Health Research Institute (www.ohri.ca/decisionaid) which also 
provides a personal decision guide and an interactive tool to explore different 
decisions.  
Given the variable quality of the available patient decision aids, a group of 
experts from 14 countries established a consensus on a set of criteria for judging 
their quality (Elwyn et al., 2006[87]). These criteria are categorized into the 
domains of essential content, development process, and evaluation. The 
International Patient Decision Aid Standards (IPDAS) is available as a checklist 
(www.ipdas.ohri.ca) and is currently being used to rate the quality of patient 
decision aids that are publicly accessible. These quality ratings are available at 
www.ohri.ca/decisionaid(see Decision Aid Library Inventory). The IPDAS 
checklist was designed to be used by developers, patients, health care 
professionals, health care insurers, administrators, policy makers, and researchers 
to critically appraise individual decision aids or to compare across available 
decision aids on the same topic. 
 Patients can access most current decision aids directly on the Internet or 
through the help from health care professionals or disease-specific community 
resource programs (O’Connor,Wennberg  and Légaré, 2007 [88]). For example, 
several cancer programs have integrated decision aids and decision quality 
measures within the process of care for women with breast cancer considering 
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treatment options (Silvia and Sepucha, 2006 [89]; Kearing et al., 2006[90]). In 
primary care, cancer screening decision aids have also been incorporated into 
routine medical visits (Brackett et al., 2007[91], Brooks et al., 2006[92]). 
Access to Decision Aids can have substantial impact on patient decisions. 
(Kennedy et al., 2002[93]). A systematic review of more than 80 randomized 
controlled trials found wide differences between the choices made by patients 
facing elective decisions who had access to decision aids versus patients who 
received usual care – who were informed by their providers.(Stacey et al., 
2011[94]).  Compared with patients who got usual care, patients who had access 
to a decision aid were better informed about their treatment options; more 
satisfied with their decision; experienced less discomfort, greater reduction of 
symptoms and more improvement in general medical conditions; had less conflict 
about the decision once they made it; and were 20% less likely, on average, to 
choose the more invasive option. There was no difference in outcomes among the 
groups. 
 As stated above, access to decision aids tool should be considered when 
we build decision aids tool for patient. Considering this, a web-based internet site 
which allow patient to access from their home or clinic at any time will be 
developed as a decision aid format. This computer program will be implemented 
as a decision support system for patients. More details on the decision support 
system are given in Section 2.5. 
2.5 Decision Support System 
 
2.5.1 Concept of Decision Support System (DSS) 
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A decision support system aims to support making business or personal 
decisions. Technically speaking, a decision support system (DSS) is an interactive 
knowledge-based, software information system. Such a system compiles the 
information from multiple sources, such as raw data, documents, guidelines, and 
scientific models, in solving problems and making decisions.  
2.5.2 Type of Decision Support System 
 
No universally-accepted taxonomy has been established for DSS. 
Depending on whether the system uses knowledge or not, DSS can be roughly 
classified as knowledge-based or non-knowledge-based. From the user’s 
perspective, DSS can be labeled as passive, active, or cooperative. A passive DSS 
is a system that aids the process of decision making, but does not bring out 
explicit decision suggestions or solutions. A cooperative DSS uses an iterative 
process between system suggestions and user modification. After the system 
provides decision suggestions, the decision maker can modify, complete, or refine 
them and the system will use the new input to generate new suggestions. This 
process iterates until a consolidated solution is reached.  Using the mode of 
assistance as the criterion, Power (Power, 2002 [95]) differentiated DSS systems 
as being communication-driven, data-driven, document-driven, knowledge-
driven, and model-driven. In short, a communication-driven DSS supports more 
than one person working on a shared task. A data-driven DSS or data-oriented 
DSS emphasizes access to and manipulation of a time series of data. A document-
driven DSS manages, retrieves, and manipulates unstructured information in a 
variety of electronic formats. A knowledge-driven DSS provides specialized 
problem-solving expertise stored as facts, rules, procedures, or in similar 
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structures. Finally, a model-driven DSS emphasizes access to and manipulation of 
a statistical, financial, optimization, or simulation model.  
2.5.3 Decision Support System in Healthcare Domain 
 
Based on decision support theory, a DSS can be built in almost any 
knowledge domain. The healthcare domain has witnessed quite a growth in DSS 
applications, concepts, principles, and techniques. One DSS system is the Clinical 
Decision Support System (CDSS), which has been defined as "Clinical Decision 
Support Systems link health observations with health knowledge to influence 
health choices by clinicians for improved health care" by Dr. Robert Hayward of 
the Centre for Health Evidence. This definition underscores two important 
features of CDSS. First, CDSS is knowledge-based. Second, it is functional. 
CDSS incorporates interactive computer programs to achieve the function of 
assisting physicians and other health professionals with their decision making 
tasks. 
CDSS can provide support to decision making at various stages in the 
healthcare process from preventive care through diagnosis and treatment to 
monitoring and follow-up. In a clinical setting, different decision support systems 
have been developed for different stages. The most common use of CDSS at 
present is to meet clinical needs of achieving accurate diagnoses. Such CDSSs 
aim at the diagnostic tasks in the care process, hence known as Diagnostic 
Decision Support System (DDSS). Examples of DDSS systems are DXplain, 
Iliad, Meditel, QMR (The book ‘Clinical Decision Support System: Theory and 
Practice’ which was written by Et S. Berner, chapter 5). The performance of these 
systems was evaluated in Berner et al. (Berner et al., 1999 [96]). 
30 
 
 Another popular use of CDSS is to provide physicians and pharmacies 
with convenient prescription ordering systems. These systems bear different 
names like Clinical Physician Order Entry, Computerized Physician Order Entry 
or Computerized Prescriber Order Entry, all abbreviated as CPOE. In essence, 
COPE is a process of electronic entry of medical practitioner instructions for the 
treatment of patients (particularly hospitalized patients). These instructions are 
communicated over a computer network to relevant constituents of the healthcare, 
including hospital staff, pharmacy, laboratory and radiology, which are 
responsible for fulfilling the order. Using a computerized system decreases delays 
in order completion, reduces clerical errors such as those due to handwriting in 
transcription, allows order entry at the point-of-care or off-site, provides error-
checking for duplicate or incorrect dosages or tests, and simplifies inventory and 
posting of charges. Statistics have shown that CPOE are able to reduce the general 
medication error rate by 80% and errors with serious potential patient harm by 
55% (Colpaert et al., 2006[97]). Other studies have also suggested extra benefits 
of CPOE, such as automatic dosage alerts (e.g., letting the user know that the 
dosage is too high and thus dangerous) and interaction checking (e.g., telling the 
user that two medications taken together could cause health problems).  
CDSS can also be tailored for particular conditions or types of patients. 
Such a system will have access to guidelines and other external databases so that 
it can provide specific information to those patients. It can also be programmed to 
send reminders for preventive care and alerts about potentially dangerous 
situations.  
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To sum up, CDSS can lower cost, improve efficiency, and reduce 
inconveniences. In ideal cases, CDSS can address these three issues 
simultaneously. One such example is alerting clinicians to potentially duplicative 
testing. For routine tasks, such as presentation of a predefined order set, CDSS 
can relieve the clinician from the burden of reconstructing orders for each 
encounter. For more complex tasks, such as diagnostic decision making, the aim 
of CDSS is to assist, rather than to replace, the clinician. In that case, CDSS will 
offer suggestions and the clinician will filter the information, review the 
suggestions, and then decide what action to take.  
2.5.4 Gap in Decision Support System for Patient 
 
Despite the wide range of clinical decision support systems that have been 
implemented by institutions and pharmaceutical companies, no such decision 
support system has been developed with patients as primary users. In other words, 
patients have been treated as passive receivers of medical decisions. Based on our 
large-scale review as discussed in introduction section of this writing, no CDSS is 
available for patients yet. Actually, even the definition of CDSS suggests that 
their target users are clinicians and physicians, not patients. There are systems that 
can help patients keep track of their personal health records, such as Microsoft 
Vault and Google Health. However, they are more in line of a data repository with 
no decision support functionality. As primary stakeholders of medical decisions, 
patients have yet to be given adequate consideration in the CDSS system 
development. 
This huge gap is the main motivation for us to conduct this study. The 
main goal of this research is to develop a DSS that is patient-oriented rather 
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clinician-oriented. This DSS aims to provide patients and their family with 
important and specific information on the disease (e.g. lung cancer). With the help 
of this system, patients will be able to play a more active role in the shared 
decision making process. 
2.6 Patient-Oriented Evidence-Based Decision Making 
Modern medical care has been influenced by two paradigms: patient-
centered medicine and evidence-based medicine. These two paradigms have 
gained momentum rather rapidly. Today, both of them play an important role in 
daily clinical decision making. Patient-centered medicine puts a strong focus on 
patient participation by taking into account the patients’ perspective in tuning 
medical care to the patients’ needs and preferences. The uniqueness of each 
patient, such as individual needs, preferences, and emotional status, are 
emphasized as relevant factors in decision-making. Evidence-based medicine, on 
the other hand, focuses on offering the best available evidences about the most 
adequate treatment. These two paradigms are highly relevant, but yet seem to 
have operated separately. One challenge is how to bring them together. Actually, 
both paradigms can benefit from interchanging ideas and principles with each 
other. The primary goal of TreatQuest® is to integrate these two paradigms in a 
seamless manner. Patient involvement and evidences for treatment options will be 
combined, which is the main motivation for the concept of patient-oriented 
evidence-based decision making.  
The most important feature of a patient-oriented approach is that it 
provides information that matters to patients. Patients need the help of a decision 
support system that actually understands their needs and is able to provide the 
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tailored and customized information by screening out irrelevant information. A 
patient-oriented decision support system must meet the following two basic 
criteria: the system must be able to address possible questions that patients 
encounter and the system must have the power to help them make decision. 
Patient-oriented decision support systems aim to help patients generate insights 
into the decision process. They achieve this goal by educating patients about the 
options and outcomes for the disease, assessing their preferences for the outcomes 
and revealing the implications of treatment options. Throughout this process, the 
system can also help patients understand how other patients had been treated and 
what outcome they have received (Scott et al., 1999 [98]).  
The term ‘evidence-based medicine’ (EBM) is relatively new but its origin 
can be traced back to ancient Greek and Chinese medicine. The history of EBM 
can be roughly divided into four eras: ancient (before the 17th century), 
renaissance (from the 17th to the 19th century), transitional (1900-1970’s), and 
modern (after 1970’s) (Claridge & Fabian, 2005[115]). The ancient era consists of 
historical and anecdotal accounts of what may be loosely termed as EBM. In the 
renaissance era, one important figure of EBM is Thomas Beddoes, who was a 
reforming practitioner, a teacher of medicine, and an associate of leading 
scientific figures. In the book called “A Letter to the Right Honourable Sir Joseph 
Banks, Bart. P. R. S.: On the Causes and Removal of the Prevailing Discontents, 
Imperfections, and Abuses in Medicine” that he coauthored with Joseph Bank, he 
proposed to cite scientific objections (Beddoes & Banks, 1808[116]). 
It is during the transitional era of EBM that a model of ecology of medical 
care was proposed by White and colleagues in 1961 (White et al., 1961[117]). 
34 
 
This model shows a valid perspective of medical care use in the 1960s. It 
organizes the complex relationships known to affect health care and the health of 
populations and states their implications for the organization of health care, 
medical training, and research. The model has also stated geo-demographic and 
socioeconomic status as factors influencing health care use.  Despite substantial 
changes in medicinal care in recent years, such as the improved techniques for 
data collection, a reassessment of health care use by the ecology model has 
actually shown similar structures to those in the 1960s.   
In the modern era of EBM, the term “evidence based” was first used by 
David Eddy in 1990 and the term “evidence-based medicine’ first appeared in the 
medical literature in 1992 in a paper by Guyatt and colleagues(Guyatt et al., 
1992[124]). The methodologies used to determine “best evidence” was first 
established by a research group at McMaster University led by David Sackett and 
Gordon Guyatt(Sackett et al., 1993[125]; Sackett et al.,1994[126]). Sackett 
actually defined EBM as “the integration of best research evidence with clinical 
expertise and patient values” (Sackett et al., 1996[119]).   
Along with the growth of evidence-based medicine, more attention has 
been paid to patients’ expectation and request from healthcare services (Kravitz, 
2001[120]). For example, a classification system, TORP, was set up to understand 
the links between patients’ unarticulated desires and expectations, patients’ verbal 
requests, physicians’ provision of health care services, and patients’ and 
physicians’ perceptions of the visit (Kravitz, Bell & Franz, 1999[121]). The 
TORP system features 11 categories of requests for patient information and 8 
categories of requests for physician action. Using the TORP system helps 
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researchers and healthcare providers identify the most common forms of patient 
requests as well as the most successful clinical negotiations to meet those needs. 
As another example, Mayor (Mayor, 2004[122]) illustrates the process and 
components of a decision for patient in the evidence-based medicine setting, as in 
Figure 2-2. The figure clearly shows how to make decisions based on the best 
current evidence while taking into account the knowledge about the particular 
patient or services under consideration.  
 
Figure 2-2 Patient Decision Making Process in Evidence-Based Medicine  
As an information-rich enterprise, EBM has been radically transformed by 
technology advances. A greater and more seamless flow of information within a 
digital health care infrastructure can be delivered and compensated by 
incorporating electronic health records (EHRs) /electronic medical records 
(EMRs), which also opens up the possibility of developing better clinical decision 
support system and of providing cost-effective treatments for patients. For 
example, the Intermountain Project designed by Intermountain Healthcare, Inc. 
was able to offers high-quality care while reducing costs through using 
technology to heavily computerize the healthcare services (November, 
2011[123]). 
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Evidence-based decision making is another equivalent important aspect of 
the patient-oriented evidence-based decision making concept. It involves the 
explicit, conscientious, and judicious consideration of the best available evidences 
in making health care decisions (Alejandro, 2000[99]).  Evidence-based decision 
making is supported by a rapidly evolving set of methods and tools. Applications 
that support the consumer’s role in decision making has become a strong focus in 
the United States (Clancy, 2005 [100]). Consumers are looking for high-quality 
evidences to answer their questions. Those evidences offer them scientific 
information to make correct decisions. Hence, whether a patient can make 
evidence-based decisions relies on whether the patient has access to evidence-
based information. An evidence-based decision support system can make such 
information extremely handy by providing patients with access to up-to-date and 
valid knowledge at the right time, at the right place, in the right amount, and in 
the right format (Eysenbach, 2001 [101]). Moreover, this service will be delivered 
in a low cost, fast, and effective manner.   
The TreatQuest® system intends to provide an evidence-based platform 
that is built with many kinds of knowledge resources. Mainly, three types of 
evidences will be included: similar case analytical results based on the SEER 
data, clinical practice guidelines, and scientific papers published in peer-reviewed 
journals. Using these evidences, patients will become more educated about 
treatment options. They can also discuss with physicians on what the guideline 
currently offers, what clinical research have shown, and what the SEER data have 
found. This way, patients will receive the strong support at the time of decision 
making. As the information gap between patients and clinicians have been greatly 
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narrowed, patients can be more engaged and informed in the treatment decision 
making process. By bridging the patient-centered medicine with the evidence-based 
medicine, the TreatQuest® system aims to improve the overall quality of 
healthcare.  
  
38 
 
Chapter 3 Methodology 
This dissertation study employs both quantitative and qualitative research 
methods. Section 3.1 describes the overall research design, including the stages 
and the methods. Section 3.2 describes the data structure of the TreatQuest®. The 
detailed design of TreatQuest® is given in Section 3.3.  
3.1 Research Design 
 
In order to design a practical, accountable, and effective decision 
support system for patients, the system development life cycle (SDLC) model 
will be implemented. In software engineering, the SDLC concept underpins 
many software development methodologies. These methodologies form the 
framework for building the patient information system for this study. The 
SDLC model can be divided into five phases. As illustrated in Figure 3-1, 
these phases are analysis, design, implementation, testing, and evaluation. In 
applying this framework to our study, the first step is to analyze the needs of 
patients so that the functions of TreatQuest® can be defined. Based on those 
functions, the architecture of TreatQuest® is then designed. This covers all the 
desired features of TreatQuest®, such as system diagram, data model, process 
chart, and personalization logic. In the implementation phase, software code is 
written and the whole system will be built. It is at this stage that the design of 
TreatQuest® is actually translated into a complete web-based system. Finally, 
in the testing phase, functional testing, evaluation, and validation activities 
will be conducted to examine how patient actually use or like the system. 
Their feedback will also be used iteratively to further improve the system.    
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Figure 3-1 Model of the Systems Development Life Cycle 
3.2 Data Source 
 
Cancer data may be collected by Health Management Origination (HMO), 
government, and no-profit organizations. All these data sources can be used in 
TreatQuest®. They are referred as external data to differentiate from the data 
collected by TreatQuest®. There are two options to use the external data. One is 
to access those data by using web services or specific software offered by data 
providers, the so-called on-demand access. One drawback of this option is that 
data access will be restricted by a third-party service, such as the web services or 
software functions. A better option seems to store the external data in the 
TreatQuest® system so that it is always available. This requires first to gain the 
license to use the data as well as to load the data properly into the repository. This 
option gives TreatQuest® more freedom in conducting queries. Once we have a 
copy of those external data, it is more flexible to retrieve and gather information 
based on the needs.  The disadvantage of this option is we have to load the data 
into our repository first.  But once the data is loaded, we can query and 
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manipulate the data easily, so useful information can be generated based on our 
needs.  
In TreatQuest®, the second option was adopted. Figure 3-2 illustrates the 
internal data repository of TreatQuest®. At the top of the chart is the data source, 
which includes the possible external data as listed in the external static data 
source box. TreatQuest® makes a copy of these data and stores them in the 
repository. In addition to the external data, the TreatQuest® internal repository 
also features research literature, guidelines, and patient data collected by 
TreatQuest®, referred as internal data in the figure. The internal data consist of 
both user information and patient information. User information includes user 
name, password, email, and security related information. Patient information 
includes demographic information, diagnose information, staging information, 
and histology information, which can be used to build dynamic queries to retrieve 
treatment-related information.  With all these data, TreatQuest® internal 
processing engine can easily retrieve relevant data and information from the 
internal repository in generating dynamic query results to users. For example, 
using the collected patient information and the SEER data, similar cases can be 
retrieved and analyzed for a user.  
Moreover, TreatQuest® can retrieve data and information that resides 
outside of TreatQuest®. Those data are referred as external data repository at the 
bottom of Figure 3-2. By adapting Google customized search function, 
TreatQuest® external processing engine can gather information and display them 
in TreatQuest® without going to those external websites. This way, users can 
easily retrieve information from external websites, such as WebMD. In addition 
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to the search function, links to those data are also provided. Figure 3-2 also shows 
how TreatQuest® uses internal data repository. By combining the information 
from the internal and external sources, TreatQuest® provides hybrid information 
to the end users, who can then use various criteria in conducting dynamic queries. 
In this sense, TreatQuest® could be viewed as hybrid, dynamic data, information 
and knowledge resources for patients. 
 
Figure 3-2    TreatQuest® Data/Information Organization 
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3.2.1 SEER Data 
 
The Surveillance, Epidemiology, and End Results (SEER) program is 
offered by National Cancer Institute (NCI), which has collected and published 
cancer incidence, prevalence, and survival data from population-based cancer 
registries since 1973. SEER data is unique in that it covers approximately 26 
percent of the U.S. population. The SEER registries routinely collect data on 
patient demographics, primary tumor site, tumor morphology, stage at diagnosis, 
and first course of treatment, and they follow up with patients for vital status. 
Moreover, the SEER Program is the only comprehensive source of population-
based information in the United States that actually collects information on the 
stage of cancer at the time of diagnosis. It also provides patient survival data for 
the analysis of longitudinal trends. By using SEER data, it is possible to provide 
population level cancer related case match for site and stage of disease. 
SEER data consist of 124 data items. A detailed description of all items is 
given in the Appendix A. The original SEER data file is in the text format.  In 
order to use such a large SEER dataset in TreatQuest®, both data load and data 
preprocessing process were implemented. The data load process reads a SEER file 
and inserts it into a temporary database table. The data preprocessing inserts the 
necessary data items from the temporary database table to the TreatQuest® tables. 
By these two steps, SEER data will be used more effectively and efficiently in 
TreatQuest®.  
3.2.2 Data Load  
SEER data comes with a structured directory in the ASCII text format. 
Based on different cancer sites, data from different SEER registries are stored in 
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different data files. Figure 3-3 is an example of the directory structure and files of 
respiratory cancer data from different SEER registries. To use these SEER data as 
internal repository, they have to be imported into the TreatQuest® system. 
 
Figure 3-3   Example of SEER Data Directory Structure 
To load the SEER ASCII text format data file, a SSIS package has been 
developed. The control flow of this SSIS package is shown in Figure 3-4.  By 
running this SSIS package, all related information from SEER data sources can be 
loaded and stored as tables.  
Following that, a database named SEER_Data_Load was created, which 
will serve as the host of SEER data and information. In essence, this loading 
process converts the original SEER data elements into the database columns in the 
TreatQuest® database tables so that patient cases will be represented in a 
consistent manner. This practice enables the query of similar patient cases, which 
is a crucial component of our system. The original SEER data file has information 
on patients diagnosed from 1973 to 2008 and lung cancer research data are stored 
in the filed named RESPIR.TXT in each sub-directory. Using the SSIS package, 
all the lung cancer related data from year 1973-2008 have been loaded into the 
SEER_Data_Load database. 
3.2.3 Data Preprocessing  
Data preprocessing is an important step in data mining and data analysis. 
Examples of data pre-processing functions are cleaning, normalization, 
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 Figure 3-4   Control Flow of SEER Data Load 
transformation, and selection. As described above, the data loaded into 
SEER_Data_Load database are loosely controlled, thus additional data 
preparation and filtering steps are necessary to remove noisy, redundant, or 
unreliable data.  
Not all 124 data items in the SEER data were collected for all years. For 
example, the data item of RX Summary - Surgery Primary Site is only available 
after year 1998. Another example is that data item RX Summary – Surgery Type 
was collected from 1973 to 1997 only. More importantly, new items were added 
after 2004, especially those items such as tumor size, lymph node, and metastasis 
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required for derived AJCC (American Joint Committee on Cancer) staging 
information. As these items bear significant importance in developing a patient 
support system, this study used the SEER data after 2004 only.   
Based on the clinical domain, data items that are essential for representing 
a patient’s ontology information are identified. Those items can be categorized as 
demographic information, diagnosis information, treatment related information 
(e.g., surgery and radiation), and survival information. To represent and store 
them more efficiently, data items are grouped into different database tables with 
each item being a table column.  
To complete the data preprocessing, a series of stored procedures were 
developed and implemented, as shown in Figure 3-5. These procedures import the 
filtered and converted data from SEER_Data_Load database to the final 
destination in the TreatQuest® database.  
 
Figure 3-5  Example of Stored Procedure for Data Preprocessing  
 Tables with patient information are: Patient_Demographic, 
Patient_Diagnosis, Patient_Surgery, Patient_RadiationTherapy,  and 
Patient_Survival. Figure 3-6 is a screenshot of those tables. 
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Figure 3-6 Tables in TreatQuest® after Data Preprocessing 
 
3.3 TreatQuest® System Design 
 
System design is a process of defining the architecture, components, 
modules, interfaces, data model, and process flow for a system to satisfy specified 
needs. It can also be viewed as the effort to develop an application from a 
theoretical model. This section will describe the technical details of TreatQuest®. 
Topics covered are selection of the structural elements and their interfaces, 
behaviors as specified in collaboration among those elements, composition of 
structural and behavioral elements, functionality, usability, and special features 
incorporated into the system. 
3.3.1 Architecture of TreatQuest® 
 
TreatQuest®is designed as a web application by using tools like Microsoft 
ASP.Net, Microsoft Internet Information Server, Microsoft Windows Server and 
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Microsoft SQL Server. It works in web browser such as Microsoft Internet 
Explorer.  Figure 3-7 shows the logical architecture of TreatQuest®. 
 
 
Figure 3-7 Architecture of TreatQuest® 
 
 Microsoft SQL Server is the software used as database management 
system. Raw data, processed data, and information and knowledge are stored in 
the corresponding databases of SQL Server. Query processing is divided into 
internal and external processing. The internal processing engine retrieves the 
query results from internal data repository and the external engine handles queries 
to external data sources. Both internal and external results are combined in the 
results and returned to the user simultaneously. The IIS Web Server is used to 
process requests submitted from the user’s browser. For external information and 
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knowledge query, web service technology was adapted to retrieve external 
information. 
3.3.2 Process Flow of TreatQuest® 
This section describes how TreatQuest® system typically processes an 
inquiry using the illustration in figure 3-8. Suppose a user is interested in 
obtaining the treatment information of all the cases that are similar to his or her 
case, or the so-called similar case query. When TreatQuest® server receives such 
a request, it will send the request to the TreatQuest® processing engine. The 
engine translates the query to a corresponding data query and a knowledge query 
and retrieves the result from the TreatQuest® internal data repository.  Direct 
answers will be generated by the SQL query. More sophisticated answers will 
trigger more steps in data processing, data mining, and knowledge acquisition.  
 
 
Figure 3-8   Process Flow of TreatQuest® 
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Meanwhile, TreatQuest® external processing engine will send a web service call 
to the external web service server. Results from the internal and external engines 
will be combined and returned to the user. 
3.3.3 Personalization and Tracking Patient Profile   
 
In order to keep track of the profile of a patient, different tables were 
created in the TreatQuest® database. At the frontend, users can submit their 
information via web based user interface. At backend, the information will be 
stored into the database. TreatQuest® stores user preferences by asking such 
information at registration and saving it in cookies. When a returning user is 
detected, the system will invoke the profile to personalize the use of the system.  
The personalization and tracking process is illustrated in Figure 3-9. 
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Figure 3-9  Personalization and Tracking Process in TreatQuest® 
3.3.4 Data Model of TreatQuest® 
The backend of TreatQuest® consists of databases that store data, 
information, and knowledge. These databases consist of multiple layers.  In other 
words, several layers of data and information are either stored in one database or 
distributed among multiple databases. The lowest layer stores the original 
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information while the higher layers stores more general information extracted 
from the lower layers.  For example, the SEER_Data_Load database described in 
section 3.2.3 is at the lowest layer with only the original data.  
Data in TreatQuest® are classified as primitive and high-level data. The 
former is actual data and the latter resides at the higher levels of the concept 
hierarchy. Correspondingly, a primitive-level query is a query whose constants 
involve primitive data only, whereas a high-level query is a query whose 
constants involve high-level data. To retrieve results at different levels, a query 
can be defined either at the primitive or high level. Both primitive data and high-
level data can be aggregated or summarized according to different queries. 
TreatQuest® is implemented as a web portal that provides services to its 
users. At the minimum, new visitors should be able to create an account and 
returning visitors should be able to log in. Most of pages or services are available 
only to the logged in users and as described above, information is personalized in 
some pages. For example, patients diagnosed with stage I lung cancer will see the 
Treatment Wizard for Stage I cancer only. Likewise, only treatment option for 
stage I will be offered to these patients. That is also to say, they will have 
customized access to treatment wizards based on the cancer stage.  
3.3.4.1 Security Model 
Security is a very important aspect of TreatQuest®. Patient/user 
information needs to be kept confidential under the Health Insurance Portability 
and Accountability Act of 1996 (HIPAA) and Health Information Technology for 
Economic and Clinical Health of 2009 (HITECH) Act. Personal information can 
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be modified by the patient only so that information integrity will be maintained.  
This section will discuss the security features implemented in TreatQuest®. 
In order to secure the TreatQuest® website, ASP.NET Membership 
service database was installed. The ASP.NET Membership service offers 
functions like authentication, authorization, user accounts, and user roles. Figure 
3-10 is the schema of the Membership database.  
 
Figure 3-10     ASP.NET Membership Database Schema 
Using ASP.NET Membership service and the login controls in ASP.NET 
gives TreatQuest® a powerful and convenient way to validate users by a database. 
The membership service has been implemented in the following four steps. First, 
a membership database named aspnetdb is created in SQL Server. Second, 
specification of membership option is enabled. Third, the type of membership is 
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determined and configured in TreatQuest®. Lastly, user membership account and 
configuration roles are defined.  
3.3.4.2Authentication via Forms Authentication 
Authentication is the process of ascertaining the client's identity. A client 
who has been successfully identified is said to be authenticated whereas an 
unidentified client is anonymous. A secure authentication system embodies at 
least one of the following three facets: something one knows, something one has, 
or something one is. Most web applications rely on something the client knows, 
such as password or PIN. The information used to identify a user, such as 
username and password, is also referred to as credentials.  
Forms authentication has been a popular way of securing web 
applications. Forms authentication identifies a user by prompting him or her to 
enter the credentials through a web form. Consequently, when a user attempts to 
access an unauthorized resource, he or she will be automatically redirected to the 
login page where credentials can be entered. The submitted credentials are then 
validated against a database with the user information. 
After the submitted credentials are verified, an authentication ticket will 
be created for the user. The ticket is usually stored as a cookie on the client 
computer. Subsequent visits to the same website will activate the ticket in the 
HTTP request, thereby enabling the web application to recognize the user once 
they log in. 
Figure 3-11 illustrates the forms authentication workflow from a high-
level vantage point. Notice that how the authentication and authorization pieces in 
ASP.NET act as two separate entities. The authentication system identifies who 
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the user is or reports the anonymous status. The authorization system then 
determines whether the user has access to the requested resource. For the 
unauthorized user (such as those attempting to anonymously visit 
ProtectedPage.aspx in Figure 3-11), the authorization system will report that the 
user is denied access, triggering the forms authentication system to automatically 
redirect the user to the login page. Once the user has successfully logged in, 
subsequent HTTP requests will carry a forms authentication ticket for the 
authorization purpose.  
 
Figure 3-11: The Workflow of Forms Authentication 
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3.3.4.3 Authorization, User Account and Roles 
In addition to identifying clients, a server may need to limit the resources 
or functionalities for certain requests. Authorization refers to the process of 
determining whether a particular user should have the authority to access a 
specific resource or functionality. A client must have a user account in order to 
access the protected pages in TreatQuest®. A typical user account includes the 
information a user needs to log in and use a system. A user account stores 
persistent information about a particular user. It must minimally include 
information that uniquely identifies the user, such as the user's login name and 
password. Along with this essential information, user accounts may include things 
like the user's email address, the date and time the account was created, and the 
date and time last logged in. In TreatQuest®, user account information is stored in 
a relational database at backend by Microsoft SQL Server. 
Web applications that support user accounts may optionally group users into 
roles. A role is simply a label that is applied to a user and provides an abstraction 
for defining authorization rules and page-level functionality. For example, a 
website might include an administrator role with authorization rules that prohibit 
anyone but an administrator to access a particular set of web pages. Moreover, a 
variety of pages that are accessible to all users (including non-administrators) may 
display additional data or offer extra functionality when visited by users in the 
administrator role. This way, authorization rules can be defined by role rather than 
by user. In TreatQuest®, administrators and the public are the two main roles 
specified. Figure 3-12 gives an example of extra functionalities that is offered to 
the administrator. The administrator can select a specific user account to make 
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changes like role setup, update, and account deletion. As illustrated in figure 3-13, 
the administrator of TreatQuest® can easily manage a user account in the system. 
 
Figure 3-12 Functionalities for Administrator in TreatQuest® 
Figure 3-13 User Account Management by Administrator in TreatQuest® 
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3.3.5 Patient Representation in TreatQuest® 
 
In creating a disease-related profile for each patient, TreatQuest® asks for  
demographic information, such as gender, date of birth, diagnosis time, staging 
information (e.g., tumor size, lymph node, metastasis, and staging code), 
histology information (e.g., histology code and cancer type). Figure 3-14 
illustrates all the patient information collected by TreatQuest®. This information 
serves two important roles. It describes each patient and the disease. It also 
functions as the key filters in analytical services, such as accessing the similar 
cases in public data. 
 
 Figure 3-14  Patient Information Collected by TreatQuest® 
 The patient information is stored in patient table. Figure 3-15 depicts how 
a fictitious patient is represented by a unique database record.   
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Figure 3-15  The Tabular Database Representation of Patient 
 
3.3.6 Personalized Patient Information   
TreatQuest® puts patients at the center of system design and information 
delivery. Its main goal is to furnish patients with sufficient high-quality 
information so that they can have greater power, protection, and choice in the key 
aspects of their healthcare. Practically, patients are also expected to be better 
prepared for treatment procedures and surgeries after using the system.  
TreatQuest® provides both general and specialized information. The 
general information includes: education material, disease statistics, general 
questions to the doctor, test procedures, staging information, and frequently asked 
questions and answers. Specialized information includes similar cases analytical 
information, standard treatment options based on staging, nomogram and 
guidelines. This type of information is tailored to the unique situation of each 
patient. For example, the similar case information will show what treatments the 
patients with the similar situation in the past have used and how effective they 
turned out to be.  
3.3.6.1 Similar Cases Treatment Options   
TreatQuest® conducts similar cases search by analyzing large-scale public 
data. When a patient query is received, the system will retrieve the SEER data 
using information from the patient profile. Analysis results will be generated and 
aggregated before sending back to the patient. Specifically, treatment options, 
total patient count, percentage of patients using the selected treatment and 
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survival information will be computed and reported. Figure 3-16 is a screenshot 
of TreatQuest® similar cases analysis based on the SEER data from 2004 to 2006.  
 
Figure 3-16 Similar Cases and Treatment Information Given by TreatQuest® 
Assume a patient registered with TreatQuest® who has provided 
information on gender, race, age, and staging, and histology. Based on this 
profile, patients with similar values on these criteria will be returned. Other than 
age, all criteria are defined as exact match. The age match is by group instead. For 
example, patients aged from 70-74 are treated as one group and considered as 
similar age. For staging information, the query retrieves exactly the same stage. 
Exact match was also implemented for tumor size, lymph node, metastasis, and 
histology code. Take tumor size as an example. The possible values for tumor size 
in the SEER data are T1a, T1b, T2a, T2b, and so on. The similar case inquiries 
are based on these exact values. For any item that the user didn’t give a value in 
the patient profile, similar case match return all possible cases for that item while 
filtering them by other criteria available.   
Figure 3-16 show the results of a similar case query using the SEER data 
from 2004 to 2006. The first column in the table lists treatment options that 
previous patients used. Due to the lack of chemotherapy and other treatment 
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information in the SEER data, the available treatment options are surgery only, 
radiation only, surgery then radiation, and radiation then surgery. The second 
column and third column give the number and percentage of patients receiving 
each treatment option accordingly. The survival information for the last few 
columns was based on the three year survival rate.  
3.3.6.2 Evidence-based Standard Treatment Options by Staging 
Evidence-based medicine (EMB) is defined as the best research evidence 
combined with clinical expertise and the patient’s values and preferences to select 
the appropriate treatment option.  The best research evidence means valid and 
clinically relevant research, especially from patient-centered clinical research 
(Straus, 2005[107]). EMB systematically searches a wide range of medical 
journals by applying strict criteria for the validity of research. This practice of 
evidence-based medicine requires the application of population-based data to the 
care of an individual patient (Doi, 2012 [103]). Evidence-based medicine has 
gradually emerged as integration of the best research evidence with clinical 
expertise and patient values and preferences and expectations (Eddy, 2005[104]). 
 In line with EMB, TreatQuest® provides evidence-based information on 
treatment options by cancer stage, as illustrated in Figure 3-17. This type of 
information is not only displayed with a list of treatment options but is also 
supported by evidences from empirical research, clinical expertise, and the 
clinical trial from NCI website.  
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Figure 3-17 Standard Treatment Options with Evidence-based Information 
3.3.6.3 Nomogram for NSCLC Post-Operative Radiotherapy  
When first diagnosed with cancer, many patients will ask about their 
prognosis with questions like “how long can I live?” or “what is the success rate 
of this treatment option?” Doctors usually give the survival rate based on the 
location and stage of the tumor. Commonly used statistics include 5-year survival 
rate and median survival time. For example, a doctor may tell a patient with early 
stage lung cancer that he or she has a 50% 5-year survival rate. 
In general, today’s cancer survival rate and median survival time are 
estimated from a large group of cancer patients. While these estimates do apply to 
the general population, they are not particularly accurate for individual patients, 
as they do not include patient-specific information, such as age and disease 
conditions. While doctors can make adjustments to their survival time prediction 
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by individual differences, it is more accurate to explicitly incorporate these 
important factors in the prognostic models. For example, information on tumor 
size, lymph nodes, and histology reveal important information about the staging 
of the patient, and therefore will be very useful for predicting how well a patient 
may respond to a treatment and how long s/he will survive.  
The survival prediction tool is designed to help physicians and patients 
make treatment or surveillance decisions. One such tool, prognostic nomograms, 
is incorporated into the TreatQuest®. This tool makes individualized estimation 
of prognosis for non-small cell lung cancer patients. It can help determine 
whether there will be benefit from a post-operative radiation therapy, or more 
specifically, whether there is benefit from the radiotherapy.   
Consider a 70 years old female patient with a tumor size of T3 (which is 
smaller than 2 cm from carina, chest wall, diaph) and the nodal status of N1 
(ipsilateral pulmonary or hilar lymph nodes). The cancer type is adenocarcinoma. 
Once the patient selects these options in the system, the prognosis will show these 
results: predict median survival without radiation therapy as 24 months and 
median survival with radiation therapy as 25 months. That is to say, the net gain 
from the post-operative radiation therapy is 1 month. As far as predicted 2-year 
overall survival, the percentage is 50% without radiation therapy versus 52% with 
radiation therapy, or a net gain of 2%.  With all these results available, the patient 
can weigh the pros and cons to determine the value of the post-operative radiation 
therapy to her. Figure 3-18 illustrates this nomogram example. 
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Figure 3-18  Nomogram for NSCLC Post-Operative Radiotherapy 
3.3.7 Guidelines in TreatQuest® 
According to Wikipedia, a medical guideline is a document with the aim 
of guiding decisions and criteria regarding diagnosis, management, and treatment 
in specific areas of healthcare. The term “medical guideline” is synonymous with 
clinical guideline, clinical protocol, or clinical practice guideline. Medical 
guidelines have been in use for thousands of years throughout the entire history of 
medicine. They serve as a guide for doctors to use appropriate methods of 
treatment and care. They embody the most reliable knowledge base that is 
produced or endorsed by a national, provincial, or territorial medical or health 
organization, professional society, government agency, or expert panel. 
Guidelines can address specific clinical situations (disease-oriented) or use of 
approved medical products, procedures, or tests (modality-oriented).  Guidelines 
define the role of specific diagnostic and treatment methods in the diagnosis and 
management of patients.  
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Modern clinical practice guidelines identify, summarize, and evaluate the 
highest quality evidence and most current data on prevention, diagnosis, 
prognosis, and therapy. They also define the most important questions in clinical 
practice and identify all possible solutions. They represent summarized consensus 
statements based on an examination of current evidences within the paradigm of 
evidence-based medicine. 
It has been demonstrated repeatedly that the use of guidelines is an 
effective way of improving many aspects of healthcare outcome, such as 
standardizing medical care, raising quality of care, and reducing risk. Although 
healthcare providers are obliged to know the clinical practice  guidelines and use 
them in treatment, not all clinical practice guidelines have been routinely followed 
(Gina, 2004[105]). One way to increase the use of the guidelines is to introduce 
them to the patients so that they can also use that knowledge in their decision 
making.  
3.3.7.1 ACCP Guidelines® for Patient (Small Cell Lung Cancer) 
 The American College of Chest Physicians (ACCP) has provided clinical 
practice guidelines for many years. Over the last several years, their efforts have 
been supervised by the ACCP Guidelines Oversight Committee (GOC) to ensure 
that the guidelines move as closely as possible to an evidence-based platform. 
Consequently, the guidelines provide the best available evidence-based 
recommendations for many clinical topics. The ACCP guidelines were 
incorporated in TreatQuest® as a PDF file. Figure -19 is the screenshot of ACCP 
Guideline for Small Cell Lung Cancer in TreatQuest®. 
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Figure 3-19  ACCP Guideline for Small Cell Lung Cancer Screenshot 
This ACCP guideline for small cell lung cancer contains information and 
knowledge from many different aspects. For patients, the most interesting 
information is the intervention and practices sections, which specifies the routine 
staging procedure and treatment related information. This guideline also describes 
the methodology used to collect/select the evidences, such as those based on the 
systematic review of the literature from peer-reviewed journals. This will help 
patients understand the major benefits in using clinical practice guidelines.   
3.3.7.2 NCCN Guidelines for Patients® (Non-Small Cell Lung Cancer) 
The National Comprehensive Cancer Network® (NCCN®) recognizes the 
increasing information needs of patients and has created a patient-friendly version 
of the NCCN Guidelines, which provides state of the art cancer treatment 
information in easy-to-understand language. The NCCN Guidelines for Patients®, 
based on the world-renowned NCCN Clinical Practice Guidelines in Oncology 
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(NCCN Guidelines®) for cancer care professionals, are meant to help cancer 
patients and their families better understand cancer and to prepare them to 
communicate better with physicians on treatment options. Since 2011, The NCCN 
Guideline for Patients® on Non-Small Cell Lung Cancer has been a very 
informative educational tool for both physicians and patients. 
3.3.7.3 NCCN Guidelines for Patient® representation in TreatQuest® 
(Treatment Wizards for Non-Small Cell Lung Cancer) 
Based on the NCCN Guidelines for Patients® of Non-Small Cell Lung 
Cancer Version 1.2012, different treatment wizards were implemented in 
TreatQuest®. Based on the stage of non-small cell lung cancer, the guidelines 
were divided into ten treatment wizards and one test wizard. Depending on the 
stage of the NSCLC, different treatment process flow will be given to the patient.  
The process flow is based on test results, health condition, surgery result, and 
other conditions.  
Unlike the paper brochure, the treatment wizards in TreatQuest® are able 
to provide customized information to patients. Using interactive means to retrieve 
information and knowledge, the guidelines are presented in a simplified way. 
More specifically, the Treatment wizards simulate the step by step process flow of 
a guideline. The wizard-based interface allows the guideline to be implemented as 
a series of navigation steps.  For each step, ASP.NET wizard control is used to 
collect user’s input and build forms. Based on user’s data for the current step, 
different options are presented for the next step so that the user can choose which 
direction to go.  
 An example of how NCCN guideline is represented in TreatQuest® is 
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described below. Figure 3-20 is a specific NCCN guideline for Stage IV Non-
Small cell lung cancer. For this guideline, it is divided into a series of steps. The 
first step is getting the performance status score of the patient. Based on that 
score, the second step is to provide information on the first-line treatment. The 
third step is getting the treatment response for the first-line treatment during first 
two treatment cycles. Depending on the response, the last step is offering 
treatment options after the first-line treatment.  
 
Figure 3-20  Staging IV Widespread Squamous Lung Cancer Guideline 
example from NCCN Guidelines for Patient of NSLC 
 How the TreatQuest® treatment wizards actually implements the above 
guideline is demonstrated below. The guideline rule is specified as: “For Stage IV 
widespread squamous lung cancer patients, offer chemotherapy as first-line of 
treatment if the performance status score is 2. Then, if there is no cancer growth 
during the first two chemotherapy cycles, continue for 4-6 chemotherapy cycles. 
If there is cancer growth in those chemotherapy cycles, re-evaluate the 
performance status score. If the score falls between 0 and 2, Docetaxel, 
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Pemetrexed, Erlotinib, best supportive care, or clinical trial, will be given as the 
treatment option after first-line treatment.” Figure 3-21 is the screen shot of the 
first step in the wizard. Figure 3-22 shows how the patient can obtain more 
information on treatment options. Both figures clearly demonstrate how the 
guideline is implemented in an interactive mannerin TreatQuest®.  
 
Figure 3-21   Collect performance score using treatment wizard of Stage 
IV Non-Small Cell Lung Cancer in TreatQuest® 
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Figure 3-22   First-line treatment given using treatment wizard of Stage IV Non-
Small Cell Lung Cancer in TreatQuest® 
 
3.3.8 Customized Search in TreatQuest® 
 
 TreatQuest® provides customized search functions to help patients to 
obtain evidence-based information from major cancer information websites. 
Using the customized search function, patients can easily retrieve accurate and 
updated information from major cancer sites right away. By adapting the Google 
custom search engine, TreatQuest® users can search across a set of credited sites, 
which are : MedlinePlus website (http://www.nlm.nih.gov/medlineplus/), 
National Cancer Institute at the National Institutes of Health website 
(http://www.cancer.gov), National Comprehensive Cancer Network website 
(http://www.nccn.org),  WebMD website(http://www.webmd.com), US National 
Library of Medicine’s search service PubMed website 
(http://www.ncbi.nlm.nih.gov/pubmed), and ScienceDirect 
website(http://www.sciencedirect.com).  The following section will give a brief 
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introduction of each site and what benefits they bring to TreatQuest®. 
MedlinePlus 
MedlinePlus® is a high-quality gateway to consumer health information 
from the National Library of Medicine(NLM), the National Institutes of Health 
(NIH), and other authoritative organizations. MedlinePlus® was rated  by some 
researchers as the gold-standard web-based consumer health information site 
(Schloman, 2006 [106]). 
MedlinePlus was first released by NLM in 1998. As a government-owned 
web site, MedlinePlus has offered free service with no advertisements. The site 
also uses no cookies and requests no personal information. Information at 
different levels can be requested to meet different needs of patients and families. 
For example, for users who like to know more research findings, MedlinePlus® 
integrates PubMed/MEDLINE searching engine for peer-reviewed biomedical 
journal citations on the Health Topic pages. As another example, for patients 
coping with a serious or chronic illness, MedlinePlus® can retrieve articles, 
evidence-based medicine, and consensus practice guidelines. Each MedlinePlus® 
Health Topic page features a link to the institute with primary research 
responsibility on certain disease. Users can follow the links to obtain additional 
information.  
NCI 
 The National Cancer Institute (NCI), a component of National Institutes of 
Health(NIH), is the federal government's principal agency for cancer research and 
training. The NCI was established under the National Cancer Act of 1937.The 
Public Health Service Act charged NCI with continuing and expanding programs 
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to provide physicians and the public with state-of-the-art information about the 
treatment of individual types of cancer and to identify clinical trials that might 
benefit patients while advancing knowledge of cancer treatment. The National 
Cancer Act of 1971 broadened the scope and responsibilities of the NCI and 
created the National Cancer Program, which supports research, training, health 
information dissemination, and other programs with respect to the cause, 
diagnosis, prevention, and treatment of cancer. The program also provides the 
supportive care of cancer patients and their families.  
The NCI website provides accurate, up-to-date, comprehensive cancer 
information, hence it is treated as one of the core web sites used by TreatQuest® 
that help patients acquire cancer information.  
NCCN 
 The National Comprehensive Cancer Network (NCCN) is a nonprofit 
alliance of 21 cancer centers throughout the U.S. Experts from NCCN cancer 
centers diagnose and treat all cancers, with a particular focus on complex, 
aggressive, or uncommon cancers. NCCN developed the NCCN Clinical Practice 
Guidelines in Oncology,  a set of recommendations designed to help health care 
professionals diagnose, treat, and manage cancer patient care. Additionally, 
NCCN launched its new series of NCCN Guidelines for Patients™, a consumer-
friendly translation of the NCCN Guidelines. The first two guidelines released 
cover breast and lung cancers. 
NCCN's flagship website, NCCN.org, is geared toward health care 
professionals. It provides them with access to the NCCN Clinical Practice 
Guidelines in Oncology (NCCN Guidelines®). NCCN.com is the consumer 
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website that provides the same information as the NCCN.org. Both NCCN 
websites are included in the core list of web sites used by TreatQuest® so that 
patients can conduct customized search for high quality cancer treatment 
information. 
WebMD 
 WebMD Health Services provides private health management programs 
and benefit decision-support portals to employers and health plans. WebMD is 
primarily known for its public website, which has a huge amount of information 
on health and health care, such as symptom checklists, pharmacy information, 
drug information, blogs of physicians with specific topics, and a place to store 
personal medical information. The WebMD website is a leading health portal in 
the United States. Since 2001, most WebMD’s operations have been accredited 
by URAC, the largest accrediting body for health care. In addition to the WebMD 
site itself, the WebMD Health Services also operate other health-related websites, 
such as MedicineNet, Medscape, eMedicineHealth, and RxList. WebMD is 
included in the core list of websites that patient can search via TreatQuest®.  
PubMed 
PubMed website is an online retrieval service developed by the National 
Center for Biotechnology Information (NCBI) at the National Library of 
Medicine (NLM). PubMed offers free access to MEDLINE, a database of over 10 
million bibliographic citations, indexed citations and abstracts to medical, 
nursing, dental, veterinary, health care, and preclinical sciences journal articles. 
PubMed also contains links to the full-text versions of articles at participating 
publishers' web sites, biological data and sequence centers from third parties. 
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Moreover, PubMed grants access and links to the integrated molecular biology 
databases maintained by NCBI. Apparently, adding PubMed into the core list of 
website in TreatQuest® greatly enhances the capacity of users in retrieving 
research articles.  
ScienceDirect 
ScienceDirect is one of the world's leading sources of scientific, technical, 
and medical research. It is a full-text database offering articles and book chapters 
from more than 2,500 peer-reviewed journals and more than 11,000 books. There 
are currently more than 11 million articles/chapters, a content base that is growing 
at a rate of almost 0.5 million per year. The ScienceDirect platform offers 
sophisticated search and retrieval functions that enable users to maximize the 
effectiveness of their knowledge discovery process. For example, by setting the 
filter with lung cancer, users can retrieve research papers in this specific area. 
ScienceDirect is incorporated into TreatQuest®. 
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Chapter 4 Evaluation and Results 
 
4.1 Introduction 
 
As a discipline, human-computer interaction (HCI) is concerned with the 
design, evaluation, and implementation of interactive computer systems for 
humans.  Such systems can be evaluated with respect to many different aspects, 
for example, functionality, reliability, usability, efficiency, maintainability, and 
portability. Due to the explosive growth of interactive software in the last decade, 
usability has gained prominence in system evaluation. Accordingly, our focus in 
evaluating the TreatQuest® system will be on its usability.  
Different definitions of usability have been proposed.  Shackel (Shackel, 
1991[107]) defines usability of a system as “the capability in human functional 
terms to be used easily and effectively by the specified range of users, given 
specified training and user support, to fulfill the specified range of tasks, with in 
the specified range of environmental scenarios”. One standard definition is 
provided by the International Organization of Standards (ISO). The ISO 9241-11 
standard, also titled Ergonomic requirements for office work with visual display 
terminals, states that “usability of a product is the extent to which the product can 
be used by specific users to achieve specific goals with effectiveness, efficiency, 
and satisfaction in a specific context of use.” This definition underlines that for a 
system to be usable, users should be able to achieve its functions with 
considerable ease. While the ISO 9241-11 recommendations have become the 
standard in the usability research, the most widely adopted definition of usability 
in system evaluation is the one introduced by Nielsen (Nielsen,1993[108]). It 
provides a detailed model in terms of usability constituents, hence it is more 
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suitable to be objectively and empirically verified by different evaluation 
methods. The Nielsen’s definition of usability is comprised of the following five 
components:  
1. Learnability: the ease of learning the functionality and the behaviors of the 
system. 
2. Efficiency: the level of attainable productivity once a user has learned the 
system. 
3. Memorability: the ease of remembering the system functionality. This 
refers to how easily a casual user can return to the system after a period of 
non-use.   
4. Few errors: the capability of the system to feature a low error rate, to 
support users making fewer errors in using the system, and in case an error    
 is made, to help them to recover easily. 
5. User satisfaction: the level users find the system pleasant to use. 
4.2 Evaluation Methods 
The usability of a system can be evaluated by multiple techniques and 
methods. Three types of usability evaluation methods are empirical method, 
inspection method, and inquiry method. The empirical method is user-oriented. It 
is based on the systematic evaluation of users’ experience with a system. The 
inspection method, on the other hand, is specialist-oriented. A specialist, such as 
a software developer, can examine the usability-related aspects of a user 
interface. The inquiry method focuses on the interaction between users and 
professionals. A specialist may ask a user how he or she likes, dislikes, and 
understands the system by oral and written communication. A specialist may also 
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observe how a user actually uses the system in real work. Table 4-1 summarizes 
the methods used by the above three evaluation categories.  
Table 4-1   Usability Evaluation Methods 
Method Category Methods 
Inquiry Method 
o User satisfaction questionnaire 
o Field observation 
o Focus group 
o Interviews 
Empirical Method 
o Thinking aloud method 
o User performance test 
o Remote usability test 
o Beta test 
o Forum test 
o Cooperative evaluation 
o Coaching method 
Inspection Method 
o Expert review 
o Heuristic evaluation 
o Cognitive walkthrough 
o Pluralistic walkthrough 
o Structured heuristic evaluation 
o Perspective-based inspection 
 
Since the inquiry method tends to identify broad usability problems and to 
seek opinions about the systems as a whole, it was used in evaluating the 
TreatQuest® system. In applying this method, a web-based user satisfaction 
questionnaire was developed to seek the feedback from patients. Field 
observation was also conducted to evaluate the system. 
4.3 Determining the Number of Users to Test  
 
While the common wisdom may favor a large number of users to test the 
system, Nielsen has argued against that approach, as to him, elaborate usability 
tests is too costly and acceptable results can be achieved from as few as 5 users 
(Jackob,1993 [109]). A mathematical model has been established for computing 
the exact number of users in usability tests (Jackob and Landauer, 1993 [110]). 
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The model is 
(1 (1 ) )iK N λ= − −                           (EQ4.1) 
where N is the number of questions to be evaluated, λ is the probability that one 
subject is able to find the average problem, and i is the number of test subjects. 
This model can also be illustrated by curves over a common range of λ values, as 
in Figure 4-1. 
  
Figure 4-1  Relationship between Number of Test Users and Proportion of 
Usability Problems Found 
Based on a large number of experiments, Nielsen (Nielsen, 1993 [111]) 
pointed out that the average proportion of usability problems discovered by a 
single user is about 31%. Using that as the estimate of the λ value in the figure, 
we would need about 15 users to discover all the usability problems. These 15 
users could be selected by two steps: the first 5 users to identify the initial 
problems in the design and the next 10 users to validate the identified problems 
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and to look for new ones.  
4.4 Data Analysis and Result 
4.4.1 Data Collection 
 The data for evaluating TreatQuest® was collected from lung cancer 
patients who have used the system. The newly diagnosed lung cancer patients 
from Columbia St. Mary’s Cancer Center in Milwaukee were contacted to 
participate in the study.  
 Once a patient filled out the consent form, a training session was arranged 
to help the patient familiar with the TreatQuest® system. The training provided 
an overview of the system, demonstrated how to use the system, and finally 
helped the patient to setup an account and to create profile in the TreatQuest® 
system. Meanwhile, the nurse coordinator from the at Columbia St. Mary's 
Cancer Center helped the patient to prepare a disease profile in the TreatQuest®. 
Once the patient or their family member had an account with TreatQuest® 
system, they could start to use the system.  After using the TreatQuest® for a 
period of time (e.g., a month), the patient would be asked to fill out a survey to 
evaluate the system. 
4.4.2 Observation during Training 
 At each training session, I observed how the patient and their family 
members interacted with the TreatQuest® system. Their comments on the general 
features as well as specific functions were recorded and analyzed. Table 4-3 
provides some observation during training session.  
 In general, patient and/or their family members were interested in the 
value that TreatQuest offers. They indicated that the system was easy to use and 
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not hard to navigate and find information. No patient or family members 
considered themselves as computer savvy, but they expressed that the system was 
user-friendly.  
4.4.3 Survey and Survey Data  
 The main goals in evaluating the TreatQuest® system were to conclude 
how well the prototype system actually performs and also to explore how the 
users like the system. To achieve that, both qualitative and quantitative data were 
collected. The quantitative data came from the numerical rating in answering the 
likert-scale questions on an online patient survey. The qualitative data, on the other 
hand, were based on the narratives that users provided in answering short-answer 
questions. These answers helped to delve into more depth of user satisfaction.  
A patient survey was conducted to identify whether the system has 
achieved its goals, what problems users still encounter, and what 
recommendations users have for improving the systems. By adapting the afore-
mentioned Nielsen’s definition of usability to a decision support system like 
TreatQuest®, the survey covered the following 6 areas: ease of use, learnability, 
information facilitation (i.e., how quickly patients can locate information), look 
and feel consistency (e.g., how the pages look and feel), content of the site (e.g., 
whether the content will keep patients coming back), and finally, site 
organization.  
As shown in Appendix I, the whole survey has 40 items which were 
arranged in three parts. The first part asks for demographic information, such as 
education level and attitude towards Internet use for healthcare system. The 
second part consists of questions on specific TreatQuest® functions such as 
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treatment wizard and search. The final part asks questions on the overall 
impression of the system, such as how easy it is to use and navigation the 
system.  
 Survey questions were written in the format of  Likert scale. Participants 
were asked to indicate the degree of agreement with the statement on a five point 
agreement scale. These statements had been carefully selected to measure users’ 
perception and attitudes toward the benefit of using the TreatQuest®.  Figure 4-2 
gives an exemplary item. Short-answer questions were also included in the 
survey to collect more open-ended response on some aspects of the system.  
Figure 4-2  Survey Question Example 
 In practice, a patient was first introduced to the system by the developer. 
Then the patient filled out a survey to indicate the satisfaction level after using the 
system for a period of time (eg. a month). As discussed above, their answer to the 
40 items on the survey provided plentiful data on the core functions of the system, 
such as access to knowledge resources, decision support, as well as usability, such 
as intent to use and user satisfaction.   
4.4.4 Preliminary Evaluation Results 
Altogether seven patients completed the evaluation study.  Their 
demographic information was in Table 4-2. While a small sample, they did 
represent quite a diverse group. As shown in the table, they represented different 
genders, races, age groups, and stages. Two patients are female, the others 
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patients are male.  The races of the patient included both white and black. The age 
of those patients range from 54 to 79. 
Table 4-2 Characteristics of Patient Samples 
Characteristic Number of Patients (Percentage of Patients) 
Gender 
Male 
Female 
 
5 (71%) 
2 (29%) 
Age Group 
50-54 
55-59 
60-64 
65-69 
70-74 
75-79 
 
1 (14%) 
1 (14%) 
2 (29%) 
2 (29%) 
 
1 (14%) 
Race/ethnicity 
White 
Black 
 
6 (86%) 
1 (14%) 
Stage at Diagnosis 
Stage II 
Stage III 
Stage IV 
 
1 (14%) 
2 (29%) 
4 (57%) 
 
4.4.4.1 Field Observation Results 
In general, the feedback has been extremely positive. Most patients 
indicated that TreatQuest® website was clear, straightforward, and easy to find 
the treatment-related information. More importantly, patients were enthusiastic 
about the value TreatQuest® provides to them. For example, at the end of one 
training session, one couple commented: “Thank you very much to put together 
such valuable system to provide valuable source of information and knowledge. 
We are certainly looking for second opinion and want to learn more information 
and knowledge.”  Table 4-3 complies the users’ comments by topic.     
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Table 4-3 User's Comments 
 
On Education Materials:  
o This information is very helpful.  Can you print this for me now? Some of 
those questions are exactly what we want answered.  
 
o I want to check with the nurse to see if they have any brochure like this. 
o It is always nice to have the glossary of terms. You might want to know 
the meaning of some terms. 
On Treatment Wizards:  
o I think this will add to our knowledge. I'll check whether my husband had 
done tests listed here. 
 
o The information about the surgery type in the wizard is useful. 
On Similar Cases and Treatment Used 
o It is good to have similar cases information although chemotherapy and 
target therapy information are not available 
 
o Physician is considering surgery; the information about the surgery type is 
good to have. 
On Treatment Options and Evidences:  
o A lot of information presented here. I have to find time to go through.  
o Let's skip the statistics numbers 
On Nomogram 
o Which histology I should choose? What is the net benefit? 
From FAQs 
o It is convenient to have FAQs. 
On Search function 
o It is neat to have the search function and integrate all those information 
together. 
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4.4.4.2 On-line Survey Results 
Out of the seven patients who received the training of the TreatQuest® 
system, five provided survey responses. Regarding their background, four 
received higher education. All of them indicated that they were frequent internet 
users. About 60% of them indicated that they did use internet to search for health 
or medical information. They all expressed that they felt comfortable to use 
information from internet to communicate with their physicians. Along with that, 
they all agreed that the external information could help them to make 
health/treatment related decisions. With regard to the information provided by 
their physicians, while some thought it was enough, others were looking for a 
second opinion.   
Regarding the information provided by the TreatQuest® system, their 
response varied by topic. All patients agreed that education material in 
MyTreatQuest was informative and could potentially help them to communicate 
with a physician. They either agreed or strongly agreed with the statements that 
Treatment Wizard can provide a helpful guide, clear explanation and information 
that they are looking for and treatment wizard is helpful in discussing my 
treatment options with a physician. For information presented to patients, they 
indicated that similar cases and treatment used based SEER data were informative 
and would help them in making treatment decisions or communicating with their 
physicians.  
All patients were satisfied with the information provided from the “Your 
Treatment Options and Evidences Based on NCI” part. However, some patients 
were uncertain about Nomogram functions. Also, surprisingly, not all patients 
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were in favor of the statistics information provided by the TreatQuest®. Some of 
them tried to skip that during the training session. But both the Frequently Asked 
Questions and Questions to Ask My Doctor sections were deemed informative to 
all patients. 
 In general, patients found the TreatQuest® website easy to use and 
navigate. All patients agreed that the content is well organized, and website gives 
a consistent look and feel. Most of the patients (80%) agreed that the TreatQuest® 
website contains mostly the treatment related information that they are interested 
in and it also provides evidence-based information to help them make treatment 
decisions. Eighty percent patients indicated that they were very likely to 
recommend the website to other patients in the future.  
 In the survey responses, some patients also listed other website they were 
using to find lung cancer-related information. One example is the 
www.MayoClinic.com.  Some patient suggested adding diagnosis related 
information to TreatQuest® website. As far as the information that most affected 
their treatment decision, some chose side effects; some chose to prolong the 
overall survival; the majority chose doctor’s opinion.  
Overall, the survey results show that TreatQuest® performed well to offer 
evidence-related information to patients, and could play an important role in 
helping patients to make treatment-related decisions. The complete survey results 
can be seen in Appendix F.   
4.5 Physician Inputs and Opinions 
During the phase of design and testing of the TreatQuest® system, the 
physicians and nurses of Columbia and St. Mary’s hospital not only verified the 
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system but also offered valuable suggestions on how to further improve the 
system. Examples of those suggestions were:  
• limit the histology code so that it is simple to use when patients 
enter their profile information  
• add illustrative pictures to the treatment wizard for different stages 
so that users have a better idea of what “stage” means 
• add more detailed specification on the origin of clinical trials, add 
the glossary of term and 
• remove the cancer risk calculator as patients have already been 
diagnosed with lung cancer.  
All these suggestions have been implemented on TreatQuest® and the 
system has become more user-friendly. 
All physicians and nurses from Columbia St. Mary’s hospital involved 
with this study were in favor of the system. They also shared the latest research 
information in this area with the researchers. To them, TreatQuest® system is 
valuable to lung cancer patients due to its ability to help patients better understand 
treatment options, thus more ready to make a collaborative medical decision.  
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Chapter 5 Discussion 
5.1 Conclusion 
According to a recent Pew Internet & American Life report Project (Fox 
and Duggan, 2013[112]), 59% of U.S. adults indicated that they had looked for 
health information online in the past year and 35% had gone online specifically 
for figuring out the medical condition they or someone else might have. The 
report also found that the health information seekers were action-oriented and 
highly purposeful. These finding are somewhat surprising as most of these people 
have already received information from their physicians and healthcare givers. It 
is noticeable that patients and their family members join the stream of information 
pathway. One way to help these consumers is practicing consumer-centered 
health informatics.   
As a relatively young field, consumer health informatics has the potential 
to provide frameworks and strategies for designing effective health 
communication tools that empower users and improve their health decisions 
(Keselman et al., 2008[113]). It provides services in patient-focused informatics, 
health literacy, and consumer education.  It is devoted to informatics from the 
consumer or patient perspective. This new approach requires us to analyze 
consumers' needs for information, study and implement methods for making 
information accessible to consumers, and model and integrate consumers' 
preferences into health information systems.  
This dissertation advanced the consumer informatics field by contributing 
one solution, the TreatQuest® system. The overall goal in designing this patient 
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decision support system was to improve the quality of decision making for 
patients. This has been achieved by using evidence-based knowledge and large-
scale data and building in inquiry functions to provide patient-tailored 
information. As a web application, the system is always available to patients. By 
following the software development cycle and web design principles, the system 
is stable and highly user-friendly. Using this system, patients can generate in-
depth insights into the decision process. They can educate themselves about the 
disease, compare different treatment options and their outcomes, and study the 
implications of their preferred treatment. Hopefully, a DSS like this will play a 
key role in the decision process of many patients. 
This dissertation research provides many insights on how to design an 
effective patient decision support system. The prototype was set up to help lung 
cancer patients to access evidence-based information and knowledge. The design 
can be easily applied to develop systems focused on other diseases. The key 
components for the systems include high-quality large-scale data source and 
analytic tools, industry guidelines and other knowledge bases, interactive search 
functions, user friendly interfaces, and web application. When these components 
are synthesized into a system, patients have a reliable resource to seek high-
quality information. The system evaluation results show that the use of 
TreatQuest® can actually help patients obtain the targeted information and 
enhance communication with physicians to achieve shared decision making.  
5.2 Limitations of the Study 
 
Several limitations exist for the current study. First, treatment information 
is limited to what is available from the SEER data. As commented by patients in 
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the evaluation study, no chemotherapy and target therapy information are 
included in the system, hence users will not be able to look for similar cases along 
those lines, which are actually quite standard treatments.  Second, so far, 
TreatQuest® does not have the capacity to support all browsers as the system 
was built using the Microsoft technology. As the attention has been mainly on 
how to build an efficient and stable system, compatibility has not been given 
enough care. While most functions are supported in most browsers, there are 
functions that do not work as designed in some browsers. Third, the sample 
size for system evaluation is small. While tremendous effort has been put into 
recruiting by me and my advisor, and the hospital had been very cooperative, the 
data collection has taken much longer than expected, the sample size was still 
quite small, maybe due to the following reasons. First, the number of lung cancer 
patients a hospital treats is limited. Second, many patients are not willing to 
participate in a research study, which is understandable, considering their 
health status. Even for those who participated, not all of them return the survey 
results. The small number of responses limits our ability to draw any significant 
conclusions. Though they did provide many insightful, usually positive, 
comments about the usability of the system, no usability or performance 
problems were identified.  
Newly diagnosed older lung cancer patients who have lived into later years of life 
may have concurrent ailments (e. g, diabetes, chronic obstructive pulmonary disease, heart 
disease, arthritis, and hypertension). In other words, they usually have multiple health 
problems.  Those comorbidities could affect treatment choice, prognosis, and survival 
since comorbidity has an important impact and greatly increases the complexity of 
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managing disease in patients.  TreatQuest® will not able to give all guidelines and 
treatment information for those complicated cases. The guidelines given by the 
system will not address how other comorbidities may inﬂuence the treatment 
decisions and the cancer course either.  
5.3 Future Directions 
 The first direction is to extend the prototype to other types of cancer. 
While lung cancer is the most popular cancer, patients of other types of cancer 
need as much help. One critical step in the extension is to locate the high-quality 
data source, such as the SEER-Medicare data. In addition, industrial guidelines 
are also helpful. The other important aspect is to understand the needs of patients.  
One feature that can be expanded is the survival prediction function. The 
current system took advantage of a module to conduct survival prediction 
analysis. Future research can work on building a more customized survival model 
based on the population data.  
Another direction for future research is to extend the system to mobile 
devices. One important feature of a decision support system like TreatQuest® is it 
is available all the time. Though mobile devices have been adopted to deliver 
many health services (Wu et al., 2005 [114]), how suitable they are for a patient 
decision support system is unclear and asks for further study. This direction can 
also include to expand the social networking features in the system. Social 
networking technology is shaping how people and organizations interact and 
share information. Studies can be designed to understand how social networking 
impacts patient decision making as well as how to integrate social networking in 
the decision support system.  
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Appendix E: TreatQuest® User Survey 
First, we want to thank you for participating in this survey about the TreatQuest 
website.Your responses will be kept strictly confidential and be used for research 
purpose only. Only aggregated group level will be reported.  
This survey will ask questions on how you like the TreatQuest website. To answer 
a question, please click the option following each question which best describes 
your situation. We are looking for your honest opinion on how this website may 
be able to help patients like you. The survey takes about 10 to 20 minutes. Your 
participation in this study is comorbiditypletely voluntary. If you have questions 
about the survey, please contact Dr. Hemant Jain at 414-229-4832 or by email at 
jain@uwm.edu. Your feedback will help developer of TreatQuest improve this 
website to better serve more users like you in the future.  
 
Part I Questions about your background 
 
1. What is the highest level of your education? 
a) Doctoral Degree 
b) Master Degree. 
c) 4-Year College 
d) 2-Year College 
e) High School 
f) Less than High School 
g) Other 
 
2. How often do you use the internet?  
Very Often like on daily basis 
Often like few times a week 
Occasionally like once or twice a month 
Seldom like once or twice a year 
Never like not use it at any place  
 
3. Do you use the internet to search for health/medical related information? 
Yes 
No 
Not Applicable 
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4. How comfortable do you feel using information from the internet to 
communicate with a physician?  
Very comfortable 
Comfortable 
Not comfortable 
Not use internet information at all 
 
5. Do you agree that information from the internet can help you make 
health/treatment related decisions?  
Strongly agree 
Agree 
Uncertain 
Disagree 
Strongly disagree 
 
6. Do you think information provided by a physician is sufficient? 
Strongly agree as they are experts.  
Agree 
Uncertain 
Disagree. I sometimes look for a second option. . 
Strongly disagree. I always look for a second option 
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Part II   Questions about My TreatQuest 
The following statements describe specific features of My TreatQuest page that 
you have reviewed. Please indicate how they describe your experience by 
selecting from the five agreement levels.  
 
 Strongly 
agree 
Agree Uncertain Disagree Strongly 
disagree 
7. Education material in My 
TreatQuest page is very informative.  
     
8. Education material in My 
TreatQuest page can help me 
communicate with a physician?   
 
     
 
Part III  Questions about Treatment Wizards 
The following statements describe specific features of Treatment Wizards page 
that you have reviewed. Please indicate how they describe your experience by 
selecting from the five agreement levels.  
 Strongly 
agree 
Agree Uncertain Disagree Strongly 
disagree 
9. The Treatment Wizards provided a 
helpful guide to my treatment options.  
     
10. Each step in the Treatment 
Wizards gave me sufficiently clear 
explanation.   
     
11. By using the Treatment Wizards, 
I was able to find the exact information 
that I was looking for.   
     
12. The Treatment Wizards was 
helpful in discussing my treatment 
options with a physician.   
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Part IV  Questions about Information for Patient 
The following statements describe specific features of Information for Patient 
page that you have reviewed. Please indicate how they describe your experience 
by selecting from the five agreement levels.  
 Strongly 
agree 
Agree Uncertain Disagree Strongly 
disagree 
13. On the Information for Patient page, 
the Similar Cases and Treatments Used 
section helped me make treatment–
related decisions.   
     
14. On the Information for Patient page, 
the Similar Cases and Treatments Used 
section helped me communicate about 
treatment options with a physician.   
     
15. On the Information for Patient page, 
the Similar Cases and Treatments Used 
section is informative.   
     
16. On the Information for Patient page, 
the Your Treatment Options and 
Evidences section is informative. 
     
17. On the Information for Patient page, 
the Your Treatment Options and 
Evidences section helped me 
communicate with a physician in regards 
to treatment options.   
     
18. On the Information for Patient page, 
the Your Treatment Options and 
Evidences section helped me make 
treatment decisions.   
     
19. The Nomogram tool is an 
informative tool to use.   
     
20. The Nomogram tool helped me 
communicate with a physician.   
     
21. The Nomogram tool helped me 
make treatment decisions.   
     
22.On the Information for Patient page, 
the Statistics section is very informative.   
     
23. On the Information for Patient page, 
the Frequently Asked Questions and 
Answers is useful.   
     
24. On the Information for Patient page, 
the Questions to Ask My Doctor section 
helped me communicate with a 
physician.   
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Part V   Questions about Search and other functions 
25. The Search function at the top of each page is easy to use.   
Strongly agree 
Agree 
Uncertain 
Disagree 
Strongly disagree 
26. The list of websites in the Search functionincluded all the major websites 
related to lung cancer.   
Strongly agree 
Agree 
Uncertain 
Disagree 
Strongly disagree 
 
27. What are the other websites you use to look for lung cancer-related treatment 
information?  
 
 
28. On the Knowledge Resources page, the similar case search criteria are easy 
to understand.   
Strongly agree 
Agree 
Uncertain 
Disagree 
Strongly disagree 
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29. On the Knowledge Resource page, which section was the most helpful for 
your treatment decision?   
Similar Cases and Treatments Used Based On SEER Data 
Treatment Option from NCI 
Statistics 
Guidelines 
Nomogram 
 
Part VI Questions about TreatQuest website in general  
 Strongly 
agree 
Agree Uncertain Disagree Strongly 
disagree 
30. TreatQuest website is easy to use.        
31. Navigating the TreatQuest website is 
easy.   
     
32. The content of the TreatQuest 
website is well organized. 
     
33. The TreatQuest website has a 
consistent look and feel.   
     
34. TreatQuest website contains most 
treatment related information that I’m 
interested in. 
     
35. The evidence-based information that 
TreatQuest provided helped me to make 
decisions regarding my treatment 
options.   
     
 
36. How likely are you to recommend TreatQuest to a patient or family member 
of a patient in the future?   
Very likely 
Somewhat likely 
Unlikely 
 
37. How likely are you to use TreatQuest as your primary source for getting 
treatment related information?   
Very likely 
Somewhat likely 
Unlikely 
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38. Do you want other non-treatment related information, such as diagnosis and 
risk factor, to be included in the TreatQuest website?   
Yes 
No 
 
39. Regarding your treatment decision, what kind of information affected you the 
most? 
 
 
40. What changes or additional features would you suggest for this website? 
 
 
 
 
End of the survey. Thanks for your feedback.  
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Appendix F: TreatQuest®:  User Survey Results 
 
Part I Questions about Your Background 
 
1. What is the highest level of your education? 
 
Doctoral Degree  0 0% 
Master Degree  1 20% 
4-Year College  2 40% 
2-Year College  1 20% 
High School  1 20% 
Less than High School  0 0% 
Other  0 0% 
 2. How often do you use the internet ? 
Very Often, like on daily basis  2 40% 
Often, like few times a week  2 40% 
Occasionally, like once or twice a month  0 0% 
Seldom, like once or twice a year  0 0% 
Never like not use it at all  1 20% 
3. Do you use the internet to search for health/medical related information ? 
Yes  3 60% 
No  2 40% 
4. How comfortable do you feel using information from the internet to communicate with a 
physician? 
Very comfortable  1 20% 
Comfortable  4 80% 
Not comfortable  0 0% 
Not use internet information at all  0 0% 
5. Do you agree that information from the internet can help you make health/treatment 
related decisions? 
Strongly agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly disagree  0 0% 
6. Do you think information provided by your physician is sufficient? 
 
Strongly agree as they are experts  0 0% 
Agree  2 40% 
Uncertain  1 20% 
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Disagree. I sometimes look for a second option.  2 40% 
Strongly disagree. I always look for a second option.  0  
Part II Questions about My TreatQuest 
The following statements describe specific features of My TreatQuest page that you have reviewed. 
Please indicate how they describe your experience by selecting from the five agreement levels. 
7. Education material in My TreatQuest page is very informative. 
Strongly Agree  2 40% 
Agree  3 60% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
 
8. Education material in My TreatQuest page can help me communicate with a physician. 
Strongly Agree  2 40% 
Agree  3 60% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
Part III Questions about Treatment Wizards 
The following statements describe specific features of Treatment Wizards page that you have 
reviewed. Please indicate how they describe your experience by selecting from the five agreement 
levels. 
9. The Treatment Wizards provided a helpful guide of my treatment options. 
Strongly Agree  3 60% 
Agree  2 40% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
10. Each step in the Treatment Wizards gave me sufficiently clear explanation. 
Strongly Agree  2 40% 
Agree  3 60% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
11.By using the Treatment Wizards, I was able to find the exact information that I was 
looking for. 
Strongly Agree  0 0% 
Agree  5 100% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
12.The Treatment Wizards was helpful in discussing my treatment options with a physician. 
Strongly Agree  0 0% 
Agree  5 100% 
Uncertain  0 0% 
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Disagree  0 0% 
Strongly Disagree  0 0% 
 
Part IV Questions about Information for Patient 
The following statements describe specific features of Information for Patient page that you have 
reviewed. Please indicate how they describe your experience by selecting from the five agreement 
levels. 
13. On the Information for Patient page, the Similar Cases and Treatments Used section 
helped me make treatment–related decisions. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
14. On the Information for Patient page, the Similar Cases and Treatments Used section 
helped me communicate about treatment options with a physician. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
15. On the Information for Patient page, the Similar Cases and Treatments Used section is 
informative. 
Strongly Agree  2 40% 
Agree  3 60% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
16. On the Information for Patient page, the Your Treatment Options and Evidences section 
is informative. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
17. On the Information for Patient page, the Your Treatment Options and Evidences section 
helped me communicate with a physician in regards to treatment options. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
18. On the Information for Patient page, the Your Treatment Options and Evidences section 
helped me make treatment decisions. 
Strongly Agree  1 20% 
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Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
19. The Nomogram tool is an informative tool to use. 
Strongly Agree  0 0% 
Agree  4 80% 
Uncertain  1 20% 
Disagree  0 0% 
Strongly Disagree  0 0% 
20. The Nomogram tool helped me communicate with a physician. 
Strongly Agree  0 0% 
Agree  4 80% 
Uncertain  1 20% 
Disagree  0 0% 
Strongly Disagree  0 0% 
21. The Nomogram tool helped me make treatment decisions. 
Strongly Agree  0 0% 
Agree  4 80% 
Uncertain  1 20% 
Disagree  0 0% 
Strongly Disagree  0 0% 
22. On the Information for Patient page, the Statistics section is very informative. 
Strongly Agree  0 0% 
Agree  3 60% 
Uncertain  1 20% 
Disagree  1 20% 
Strongly Disagree  0 0% 
23. On the Information for Patient page, the Frequently Asked Questions and Answers is 
useful. 
Strongly Agree  0 0% 
Agree  5 100% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
24. On the Information for Patient page, the Questions to Ask My Doctor section helped me 
communicate with a physician. 
 
Strongly Agree  0 0% 
Agree  5 100% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
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Part V Questions about Search and Other Functions 
 
25. The Search function at the top of each page is easy to use. 
Strongly agree  3 60% 
Agree  2 40% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly disagree  0 0% 
26. The list of websites in the Search function included the major websites on which you did 
cancer related information research. 
Strongly agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly disagree  0 0% 
27. What are the other websites you use to find lung cancer-related treatment information? 
Mayo Clinic 
 
28. On the Knowledge Resources page, the similar case search criteria are clear. 
Strongly agree  0 0% 
Agree  5 100% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly disagree  0 0% 
 
29. On the Knowledge Resource page, which section was the most helpful for your 
treatment decision? 
Similar Cases and Treatments Used Based On SEER Data  1 20% 
Treatment Option from NCI  2 40% 
Statistics  1 20% 
Guidelines  0 0% 
Nomogram  0 0% 
  Part VI Questions about TreatQuest Website in General 
30. TreatQuest website is easy to use. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
31. Navigating the TreatQuest website is easy. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
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32. The content of the TreatQuest website is well organized. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
33. The TreatQuest website has a consistent look and feel. 
Strongly Agree  1 20% 
Agree  4 80% 
Uncertain  0 0% 
Disagree  0 0% 
Strongly Disagree  0 0% 
34. TreatQuest website contains most treatment related information that I’m interested in. 
Strongly Agree  1 20% 
Agree  3 60% 
Uncertain  1 20% 
Disagree  0 0% 
Strongly Disagree  0 0% 
35. The evidence-based information that TreatQuest provided helped me to make decisions 
regarding my treatment options. 
Strongly Agree  1 20% 
Agree  3 60% 
Uncertain  1 20% 
Disagree  0 0% 
Strongly Disagree  0 0% 
36. How likely are you to recommend TreatQuest to a patient or family member of a patient 
in the future? 
Very likely  4 80% 
Somewhat likely  1 20% 
Unlikely  0 0% 
37. How likely are you to use TreatQuest as your primary source for getting treatment 
related information? 
Very likely  1 20% 
Somewhat likely  4 80% 
Unlikely  0 0% 
38. Do you want other non-treatment related information, such as diagnosis and risk factor, 
to be included in the TreatQuest website? 
Yes  3 60% 
No  2 40% 
 
39. Regarding your treatment decision, what kind of information affected you the most ? 
side affect, prolong the overall survivalDOCTOR OPINIONphysician's opinion 
 
40. What changes or additional features would you suggest for this website? 
NONEnone 
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